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A protocol is presented for the calculation of monitor units (MU) for photon and electron beams, de-
livered with and without beam modifiers, for constant source-surface distance (SSD) and source-axis
distance (SAD) setups. This protocol was written by Task Group 71 of the Therapy Physics Commit-
tee of the American Association of Physicists in Medicine (AAPM) and has been formally approved
by the AAPM for clinical use. The protocol defines the nomenclature for the dosimetric quantities
used in these calculations, along with instructions for their determination and measurement. Calcu-
lations are made using the dose per MU under normalization conditions, D′0, that is determined for
each user’s photon and electron beams. For electron beams, the depth of normalization is taken to
be the depth of maximum dose along the central axis for the same field incident on a water phantom
at the same SSD, where D′0 = 1 cGy/MU. For photon beams, this task group recommends that a
normalization depth of 10 cm be selected, where an energy-dependent D′0 ≤ 1 cGy/MU is required.
This recommendation differs from the more common approach of a normalization depth of dm, with
D′0 = 1 cGy/MU, although both systems are acceptable within the current protocol. For photon beams,
the formalism includes the use of blocked fields, physical or dynamic wedges, and (static) multileaf
collimation. No formalism is provided for intensity modulated radiation therapy calculations, al-
though some general considerations and a review of current calculation techniques are included. For
electron beams, the formalism provides for calculations at the standard and extended SSDs using
either an effective SSD or an air-gap correction factor. Example tables and problems are included to
illustrate the basic concepts within the presented formalism. © 2014 American Association of Physi-
cists in Medicine. [http://dx.doi.org/10.1118/1.4864244]
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NOTATION AND DEFINITIONS
The following defines the dosimetric quantities used for MU
calculations within this protocol.
D The absorbed dose at the point of interest
from the individual field under calculation.
D′ The dose rate or dose per monitor unit at
the point of interest.
D′0 The dose rate or dose per monitor unit of
the user’s beam under normalization con-
ditions.
d Depth of the point of calculation.
deff Water-equivalent depth of the point of cal-
culation.
d0 The normalization depth for photon and
electron dosimetry. For photons, d0 = 10
cm is recommended, but not required. For
each photon beam, d0 is independent of
field size and shall be greater than or equal
to the maximum dm.
For electrons, d0 is taken to be the depth
of maximum dose along the central axis for
the same field incident on a water phan-
tom at the same SSD.8 It is field-size de-
pendent.
dm The depth of maximum dose on the central
axis.
E The nominal beam energy of the user’s
photon or electron beam.
fair(r,SSD) Air-gap correction factor (Sec. 1.A.2.e).
The ratio of the electron dose rate at ex-
tended SSD to that predicted using only
inverse-square corrections.
OAR(d,x) Off-axis ratio (Sec. 1.A.1.f). The ratio of
the open field dose rate at an off-axis
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point to that for the same field (e.g., 10
× 10 cm2) shifted such that the point of
calculation lies on the central axis. The Pri-
mary Off-Axis Ratio, POAR, is preferred
to be used for OAR(d,x).
PDD(d,r,SSD) Percent depth dose. The ratio, expressed as
a percentage, of the dose rate at depth to
the dose rate at dm in a water phantom for
a given field size and SSD.
PDDN(d,r,SSD) Normalized percent depth dose (Sec.
1.A.1.b). The ratio, expressed as a percent-
age, of the dose rate at depth to the dose
rate at the normalization depth in a water
phantom for a given field size and SSD.
x Off-axis distance. Distance from central
axis to a fan line through the point of cal-
culation measured in a plane perpendicu-
lar to the central axis at the isocenter. As
such, x represents the radial distance rather
than the distance along either principal
axis.
ra The applicator size for electron beams.
rc The side of the equivalent square for the
collimator field size defined at isocenter.
r, rd The side of the equivalent square for the
field size incident on the patient, defined at
the surface and at depth d, respectively.
r0 The side of the equivalent square for the
reference field size for photon and electron
dosimetry. The reference field size within
this protocol is 10 × 10 cm2, defined at the
isocenter.
Se(ra,r) Output factor for electron beams (Sec.
1.A.2.c). For electrons, the ratio of the dose
rate at dm for a given applicator, field size,
and SSD to the dose rate at dm for the ref-
erence applicator, reference field size, and
reference SSD.
Sc,p(rc,rd) (In-water) output ratio. The ratio of the
dose per MU in phantom for a given field
size to that for the reference field size. Sc,p
is measured at the normalization depth in
a water phantom and depends on field size
and the choice of normalization depth. The
increase in scatter dose with field size is
due both to increased energy fluence orig-
inating from the collimator head and from
scattered photons within the phantom. Sc,p
is approximated to be separable into ma-
chine (collimator) and phantom-dependent
components.
Sc(rc) In-air output ratio (Sec. 1.A.1.d). The ra-
tio of the output (i.e., energy fluence) in air
for a given field size to that for the refer-
ence field size. Sc represents that compo-
nent of Sc,p excluding changes in scattered
radiation from the irradiated volume in a
phantom.
Sp(rd) Phantom scatter factor (Sec. 1.A.1.e). The
ratio of the dose per MU at the normaliza-
tion depth for a given field size in a water
phantom to that of the reference field size
for the same incident energy fluence.
SAD Source-axis distance. Distance between
the x-ray physical source position and the
isocenter. For most linear accelerators, this
value is nominally 100 cm.
SPD Source-point distance. The distance from
the x-ray physical source to the plane (per-
pendicular to the central axis) that contains
the point of calculation.
SSD Source-surface distance. The distance
along the central axis from the physical
source to the patient/phantom surface.
SSD0 Standard source-surface distance. The dis-
tance along the central axis from the phys-
ical source to the patient/phantom surface
under normalization conditions.
SSDeff Effective source-surface distance. The dis-
tance along the central axis from the effec-
tive source to the patient/phantom surface,
determined by best fit of output versus the
inverse of the distance squared.
TPR(d,rd) Tissue phantom ratio (Sec. 1.A.1.c). The
ratio of the dose rate at a given depth in
phantom to the dose rate at the normaliza-
tion depth for a given field size.
TF Tray factor. The ratio of the central-axis
dose rate for a given field with and without
a blocking tray. TF is assumed independent
of depth and field size in this report. This
factor may be used to account for the atten-
uation through additional materials (e.g.,
special patient support devices) as needed.
WF(d,rd,x) Wedge factor (Sec. 1.A.1.i). The ratio of
the dose rate at the point of calculation for
a wedged field to that for the same field
without a wedge modifier. The wedge may
be a physical filter or not (i.e., dynamic or
virtual). Depending on the type and angle
of the wedge modifier, WF may depend on
the wedge angle, field size, depth, and off-
axis distance.
1. INTRODUCTION
On the basis of clinical dose-response data, the Inter-
national Commission on Radiation Units and Measurement
(ICRU) states that dosimetry systems must be capable of de-
livering dose to an accuracy of 5%.1 Furthermore, improve-
ments in this level of accuracy are warranted to improve the
modeling and prediction of dose-volume effects in radiation
therapy.2 Many factors contribute to both random and system-
atic deviations in dose delivery, including daily patient setup,
target delineation, and dose calculation. It is apparent that the
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errors associated with each step of the treatment process must
be substantially less than the overall tolerance. Thus, as im-
provements are made in immobilization techniques, patient
setup, and image quality, similar improvements are necessary
in dose calculations to obtain greater accuracy in overall dose
delivery. The accurate determination of dose per monitor unit
(MU) at a single calculation point is an essential part of this
process.
The calculation of MUs has evolved over the past sev-
eral years as treatment planning has increased in accuracy
and complexity. Historically, MUs were determined using a
manual calculation process, where the calculations were
based on water phantom data gathered at time of machine
commissioning. Over time, manual calculations have become
more accurate due to more detailed characterizations of dosi-
metric functions. Nevertheless, these calculations are based
on machine data, which are typically gathered with a flat, ho-
mogeneous water phantom.
Additional improvements in dose-calculation accuracy
within computer treatment-planning systems have been made
possible with the incorporation of patient-specific anatomical
information. Early computer algorithms calculated the two-
dimensional scatter characteristics based on patient-specific
external contour information.3 The advent of image-based
treatment planning has allowed incorporation of patient-
specific internal heterogeneity information into the calcula-
tion of dose. The use of this information to determine the
dose through a complex two- or three-dimensional algorithm
is limited to a “computer calculation,” although a subset of
this information may be used to improve the accuracy of a
manual calculation (e.g., the use of an effective or radiologi-
cal depth).
Despite the improvements possible with current and fu-
ture computer-calculated MUs, manual calculations will be
still required for several reasons. First, some patients may not
require a computerized treatment plan and it may be most
efficient to calculate the MU for their treatments manually.
This is especially common in the palliative or emergent set-
ting. Second, although the computer calculation may incor-
porate additional information, there is no assurance that the
computer-calculated MUs are more accurate for all condi-
tions. There are a number of different commercial treatment-
planning systems available, each of which has a different
technique for determining dose. For example, with some
computer algorithms, it may be difficult to model a partic-
ular clinical setup or accessory. Finally, both Task Group
(TG)-40 and TG-114 of the American Association of Physi-
cists in Medicine (AAPM) recommend4, 5 that the output of
a computer calculation be independently verified with an
alternative calculation method. This check becomes more
important as the sophistication of the planning algorithm
increases.
Many manual methods are currently being used to deter-
mine MUs. The use of many different approaches increases
the probability of calculational errors, either in the misunder-
standing of varying nomenclatures or in the absence or misuse
of important parameters within the calculation formalism.
Furthermore, using multiple approaches results in reduced
clinical workflow efficiency. In addition to the time required
for each clinic to develop inhouse MU calculation protocols,
the retraining of personnel who move between clinics or the
interpretation of clinical data from other clinics is made more
difficult when different calculational approaches are used.
The clinical application of the formalism presented within is
the subject of another AAPM report.5
This task group report presents a consistent formalism for
the determination of MUs for photons and electrons. For pho-
tons, the report describes MU calculations for fields with and
without beam modifiers for both isocentric and source-surface
distance (SSD) setups. The protocol includes the use of dy-
namic or virtual wedges (VW) and static multileaf collima-
tion. Although intensity modulated radiation therapy (IMRT)
calculations are beyond the scope of this report, a brief review
of current algorithms is made, along with general recommen-
dations of this task group. The current protocol is applica-
ble for megavoltage linear accelerators or Co-60 teletherapy
units. For electrons, calculations for standard or irregularly
shaped fields at standard or extended SSDs are described.
The protocol’s calculations are referenced to D′0, the dose
per MU or dose rate of the user’s beam under normaliza-
tion conditions. At the time of calibration, the output of each
beam is adjusted to deliver a specific D′0 that is determined by
the user. Under normalization conditions, although many of
the dosimetric functions within this protocol have a value of
unity, D′0 is not necessarily 1 cGy/MU, and may vary between
beams.
Here we differentiate normalization conditions from
reference conditions, the latter of which represents the mea-
surement conditions for the determination of absorbed dose to
water within the AAPM TG-51 protocol.6 For example, TG-
51 specifies that the reference depth, dref, be equal to 10 cm
for photon beam calibration. In this report, the photon beam
normalization depth, d0, is distinct from but may be equal to
dref (10 cm), or to any other depth at or beyond the maximum
depth of dm. For electron beams, the normalization depth for
a given field is taken to be the depth of maximum dose along
the central axis for the same field incident on a water phantom
at the same SSD.7, 8
The choice of the normalization depth(s) for photon beams
should be made after considering several issues. If d0 is dif-
ferent from dref, it is necessary to convert the calibration dose
per MU at dref to the dose per MU at d0. This conversion in-
troduces a potential source of error if the percentage depth
dose data used for this conversion are inaccurate and/or dif-
ferent from the data used elsewhere in the MU calculation.
Additional uncertainty arises if d0 is set equal to dm, where it
has been noted that electron contamination within the pho-
ton beam makes the determination of dose in this region
more difficult.9 Furthermore, other studies have shown that
for higher energy beams, electron contamination penetrates
much farther than dm.10, 11 Choosing d0 = 10 cm for photon
beams eliminates the uncertainty associated with converting
the calibrated output to the dose rate at other depths, particu-
larly at dm.
Choosing a normalization depth of 10 cm has additional
advantages. Different machines of the same energy will be
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matched at a more clinically relevant depth, which may de-
crease the differences in programmed MU when moving
patients from one machine to another. Some of the field-
size dosimetric quantities vary less significantly at depths
greater than dm, making dosimetric measurements less sus-
ceptible to setup error. Some treatment-planning systems re-
quire measured output factors at a depth of 10 cm, thus
requiring users to measure these data anyway. Choosing a
normalization depth of 10 cm eliminates the duplication of
effort, either at time of commissioning or during annual
inspections.
Thus, this task group recommends that the normalization
depth be set to 10 cm for photon beams. However, the for-
malism presented within this protocol is valid for any choice
of d0. If another depth is chosen for d0, at a minimum this
depth shall be greater than or equal to the maximum dm
depth, determined from percent depth dose measurements
for the smallest field size and greatest SSD used clinically.
It is recognized that a 10-cm normalization depth repre-
sents a change for most clinics. To aid the clinician in the
development of data tables, we have included a set of exam-
ple tables which have been normalized at this depth. A set of
example problems have also been included in Sec. 8 of this
report.
2. CALCULATION FORMALISM
2.A. Photons
MU calculations for photon beams may be performed
using either a TPR (isocentric) or PDD (nonisocentric)
formalism.
2.A.1. Monitor unit equations
2.A.1.a. Photon calculations using tissue phantom ratio.
For calculations using TPR, the equation for MU is given by
MU = D
D′0 · Sc(rc) · Sp(rd ) · TPR(d, rd ) · WF(d, rd, x) · TF · OAR(d, x) ·
(
SSD0 + d0
SPD
)2 . (1)
In the case where dose is calculated at the isocenter point, Eq. (1) reduces to
MU = D
D′0 · Sc(rc) · Sp(rd ) · TPR(d, rd ) · WF(d, rd ) · TF ·
(
SSD0 + d0
SAD
)2 . (2)
2.A.1.b. Photon calculations using percentage depth dose. Although Eq. (1) may be used to determine MUs for any setup,
including nonisocentric cases, it may be preferable to use normalized percentage depth doses in some circumstances. In this
case, the MU equation is given by
MU = D · 100%
D′0 · Sc(rc) · Sp(rd0 ) · PDDN (d, r, SSD) · WF(d, rd, x) · TF · OAR(d, x) ·
(
SSD0 + d0
SSD + d0
)2 . (3)
2.A.2. Field-size determination
Many of the dosimetric functions in Eqs. (1)–(3) are field-
size dependent due to the variation in scattered radiation orig-
inating from the collimator head or the phantom. Dosimetric
functions are usually tabulated as a function of square field
size. In general, values for irregular fields may be approxi-
mated by using the equivalent field size, defined as the square
field that has the same depth-dose characteristics as the ir-
regular field.12 In many cases, the treatment-planning system
will report the equivalent square of the photon beam. In this
case, users should understand the methodology by which this
equivalent square is determined, including whether the ef-
fects of blocking and/or tissue heterogeneities are included.
The equivalent square may also be estimated by approximat-
ing the irregular field as a rectangle, and then determining the
rectangle’s equivalent square either with a calculated table12
or with the method of Sterling et al.,13 which sets the side
of the equivalent square to four times the area divided by the
perimeter of the rectangular field. This “4A/P” formula works
well in most clinical circumstances but should be verified for
highly elongated fields (e.g., 5 × 40 cm2) and for in-air output
ratios.
This Section (2.A.2) describes the determination of field
size for use in Eqs. (1)–(3).
2.A.2.a. Determination of field size for Sc. The func-
tion Sc models the change in incident fluence as the colli-
mation in the treatment head is varied. The change in in-
cident fluence can be modeled by the collimation of a pri-
mary source at the target and a radially symmetric planar ex-
tended scattered-radiation source close to the target.14–20 The
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volumes of these two sources that are not blocked by the
jaws and the field shaping collimator (e.g., blocks and MLC)
from the point of view of the point of calculation (point’s-
eye-view or PEV) determine Sc. Because this exposed re-
gion from PEV depends on both the jaw settings and the
field-shaping collimator that are at different distances from
the sources, an accurate formalism will involve a method to
combine the effects of different collimators into an equiva-
lent field size. There are three different methods to calculate
an equivalent square field size for Sc in order of increasing
accuracy: equivalent square of jaw settings, PEV model of
collimating jaws, and PEV model of all collimators. Unless
the treatment field is highly irregular (e.g., heavily blocked or
highly elongated), the equivalent square method predicts Sc
reasonably well21 and will be described in this section. A de-
scription of the PEV models is included in Appendix B of this
report.
Additionally, backscattered radiation from the adjustable
jaws to the monitor chamber will affect the collimator scat-
ter factor. Modern accelerators either have a retractable foil
between the monitor chamber and the adjustable jaws to at-
tenuate the backscattered radiation, or the collimators are far
enough from the monitor chamber so that the significance
of monitor backscatter is reduced.21 For further details, the
reader is referred to the AAPM TG 74 report.10
2.A.2.a.i. Open or externally-blocked fields. The up-
per and lower jaws are the collimators closest to the target.
Thus these collimators are the main factors determining Sc.
Although these two sets of collimators are at different dis-
tances from the source, the difference in the distances is much
smaller than the distance from the source to the isocenter. If
one makes the approximation that the upper and lower jaws
are at the same distance from the sources and they are the only
collimators that are shaping the exposed region of the sources
from PEV, the equivalent square for Sc can be modeled as
the equivalent square of the rectangle formed by the jaws at
isocenter. Using the 4A/P formula, the equivalent square used
for determining Sc will be:13
rc = 4
(
rjU · rjL
2rjU + 2rjL
)
, (4)
where rjU is the upper jaw setting and rjL is the lower jaw
setting, defined at the machine isocenter.
Equation (4) is used to determine the equivalent square for
open fields or those using externally mounted blocks. In the
latter case, the blocks are placed farther away from the tar-
get than the collimators, so that little if any of the source is
obscured from the PEV of the calculation point.
The difference in distances from the target of the upper and
lower collimator jaws results in deviations from the equiva-
lent square model. The “collimator exchange effect” describes
the differences in output when the upper and lower field-size
settings are reversed.10 The collimator exchange effect is not
modeled using 4A/P; for example, this approximation will
predict the same Sc for a 5-cm wide 40-cm long field and a
40-cm wide 5-cm long field. The error introduced by this ap-
proximation is typically small (<2%),21 but is dependent on
the accelerator design and should be measured for evaluation.
The collimator exchange effect is accounted for in the PEV
models described in Appendix B.
2.A.2.a.ii. MLC-blocked fields. Currently, almost all
linear accelerators come equipped with some form of multi-
leaf collimator, or MLC. Figures 1–3 show examples of com-
mercially available MLCs categorized as a total or partial re-
placement of the upper or lower jaws or as tertiary collima-
tion configurations. Because of the different position of each
of these configurations with respect to the target, each system
will have a different amount of scattered photons reaching the
point of calculation for the same incident field size.
Currently, the Elekta/Philips MLC is designed as an upper-
jaw replacement.22 Backup diaphragms located beneath the
leaves augment the attenuation provided by the individual
leaves. Figure 1 shows a cross-section of the Elekta head de-
sign. Measurements by Palta et al.,23 have demonstrated Sc
for the upper-jaw replacement system can be accurately cal-
culated by using the equivalent square of the MLC blocked
field area.
The Siemens MLC is designed as a lower-jaw replacement.
The upper jaws are strategically placed at the upper and lower
borders of the field. Figure 2 displays the Siemens MLC head.
Das et al.,24 characterize Sc for the Siemens system in the
same fashion as the upper jaw replacement system by using
the equivalent square of the MLC blocked field area for the
argument of Sc.
FIG. 1. Cross-sectional view of Elekta MLC head. The leaf banks are
mounted in place of the upper collimator in order to fit in the standard head
cover. Each of the 80 tungsten leaves is of 7.5 cm thickness, equivalent to
approximately two tenth value layers. A leaf has a width of 1 cm and a range
of movement 20 cm away from the central axis to 12.5 cm across it. The 3-
cm thick Y back-up diaphragm is intended to reduce any leakage through the
gaps between the leaves (Ref. 22).
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FIG. 2. Schematic diagram of the Siemens MLC head. In this design, the
double-focused bank of 54 leaves is mounted in place of the lower collima-
tor. Each of the tungsten leaves is 7.6-cm thick and projects to a 1.0-cm wide
radiation field at isocenter. All leaves can be independently moved to an over-
travel of 10 cm past the central axis (Ref. 24).
The Varian MLC is an example of a tertiary collimator
system. This device is positioned just below the level of the
standard upper and lower adjustable jaws. The y-jaws are
strategically placed at the upper and lower borders of the
field. Figure 3 describes the Varian MLC head design. Boyer
FIG. 3. Cross-sectional view of Varian MLC head for a 2100C accelerator
(Ref. 26). In this design, the leaf banks are mounted in carriages placed below
the lower collimator, with leaf widths of 0.5- or 1.0-cm projected at SAD,
depending on MLC model.
et al.25 and Klein et al.26 found that the tertiary MLC design
is best treated as a block. That is, the equivalent square of the
collimator field size is used.
2.A.2.b. Determination of field size for Sp. For Sp, the
field size is proportional to that incident on the patient. This
may be smaller than the collimator field size if the scatter
volume is reduced by either tertiary blocking or patient limits
or larger in the case of extended SSD.
The field-size argument rd of Sp in Eqs. (1) and (2) is the
equivalent square of the field size incident on the patient, pro-
jected to the depth of the point of calculation. Thus, unlike Sc,
the argument for Sp will change with a change of source-point
distance (SPD).
The field-size argument rd0 of Sp in Eq. (3) is the equivalent
square of the field size incident on the patient, projected to
the normalization depth. In some texts, the argument is writ-
ten using the field size defined at the patient surface.27 For a
normalization depth at or near dm, only a negligible difference
is found using the equivalent field size on the surface of the
patient. However, for greater d0’s (e.g., d0 = 10 cm), this ap-
proximation cannot be made. In this case, the projected field
size is relatively larger and the field-size dependence of Sp is
greater.
2.A.2.c. Determination of field size for TPR or PDDN.
As with Sp, the field size argument for these quantities is pro-
portional to that incident on the patient, which will be affected
by either tertiary blocking or patient limits.
For isocentric calculations, the field size argument for
TPR is the equivalent square of the field size incident on
the patient, projected to the depth of the point of calcula-
tion. For SSD calculations, the field-size argument for PDDN
is the equivalent square of the field size incident on the
patient.
2.A.2.d. Determination of field size for wedge factor (WF).
2.A.2.d.i. Physical wedges. Physical wedges may be
classified into two types, distinguished by their placement
relative to the secondary collimating jaws. Internal wedges
(sometimes called motorized wedges or universal wedges),
located above the collimating jaws are designed using a single
wedge with a large wedge angle (60◦). The internal wedge is
inserted into the field using a motorized drive within the accel-
erator. Wedged isodose distributions with smaller wedge an-
gles are produced by combining the internal wedge field with
a corresponding open field with appropriate relative weight-
ing. In contrast, external wedges are placed below the colli-
mating jaws. External wedges are manually inserted into the
collimator assembly, and are located much closer to the pa-
tient, with source-wedge distances ranging from 40% to 70%
of the SAD.
The field size dependency of physical wedges appears to
originate from a wedge-induced increase in head scatter.28
Investigations have determined that the WF for rectangular
fields is closely approximated by the WF of the equivalent
square for both external29, 30 and internal31 wedges, regard-
less of orientation. For wedged fields with blocks or MLCs, it
is recommended to use the equivalent square of the irregular
field for the argument of WF.32
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2.A.2.d.ii. Nonphysical wedges. Wedge factors for
nonphysical, or filterless wedges represent the fractional
change in dose per MU at the calculation depth after the treat-
ment field is completed. This protocol will discuss two current
vendor implementations of this technology.
The first step by commercial vendors to intensity modu-
late a beam was the application of the Varian dynamic wedge
(DW).33 Both DW and its successor, the enhanced dynamic
wedge (EDW) takes advantage of a collimation jaw moving in
conjunction with adjustment of the dose rate over the course
of one treatment. The variation of jaw position and dose rate is
driven by a segmented treatment table (STT), which is unique
for each energy, wedge angle, and field size. The basis for the
EDW generation is a “golden” STT (GSTT) for a 60◦, 30-cm
wedge, from which the treatment STTs for other wedge an-
gles are calculated.
In contrast to physical wedges, Varian dynamic wedges
have very steep field-size dependencies. Thus, it is critical that
the input field size be correct for the calculation. The WF for
EDW is primarily dependent on the position of the fixed Y
jaw, and is virtually independent of the X collimator setting,
the initial moving Y jaw position, and the MLC or blocked
field size.
Siemens introduced a dynamic jaw wedging system enti-
tled the VW. The VW operates similar to the Varian EDW,
with capabilities for additional intermediate wedge angles and
operation with the lower jaws, with limited range.
The most notable difference between the EDW and VW
is how the energy fluence pattern is generated. As the VW
attempts to deliver the same dose on central axis as the open
field with the same field size, the WF is designed to be unity
for a standard range of field sizes and wedge angles. The user
should verify the field-size dependency (or lack thereof) for
all field sizes to be used clinically.
2.A.3. Radiological depth determination
Equations (2) and (3) assume dose is to be delivered to a
flat, homogeneous water phantom. To correct for internal het-
erogeneities within the patient, the calculated homogeneous
dose per MU, D′(Homogeneous), is multiplied by a correc-
tion factor (CF) defined as
CF = D
′(Heterogenous)
D′(Homogenous) . (5)
Methods of varying levels of complexity exist in the literature
for determining CF.34 Many of these are impractical for ap-
plication in a manual calculation. Two methods that may be
employed are detailed below.
Each of these simple methods relies on attenuation data,
typically measured under conditions of electronic equilib-
rium. Unfortunately, data in nonequilibrium conditions (e.g.,
d < dm) are suspect and often not even measured. Physicists
must use caution with these solutions and not, for example, try
to calculation CF in locations near heterogeneity interfaces.
2.A.3.a. Method 1. This method represents the simplest
technique for determining the heterogeneity correction fac-
tor. It is used in the simplest heterogeneity correction meth-
ods that examine only the path of primary radiation.35 Of-
ten called the ratio of TAR method, or RTAR, the correc-
tion factor uses a water-equivalent or radiological depth, deff,
calculated along the line from the source to the point of
calculation:
deff =
n∑
i=1
di · ρe,i , (6)
where di and ρe,i are the distance and relative electron den-
sity (respectively) for the ith element along the line. For cal-
culations based on CT-based treatment planning, this scaled
depth is often reported by the treatment-planning system. In
this case, the correction factor is given by
CF = TPR(deff, rd )
TPR(d, rd )
. (7)
2.A.3.b. Method 2. The method, known as the power law
TAR or the Batho method,36 determines the dose for calcula-
tion points beneath a heterogeneity. In this method, the cor-
rection factor is given by
CF =
(
TPR(d1, rd )
TPR(d2, rd )
)ρe−1
, (8)
where ρe is the electron density of the inhomogeneity relative
to water and d1 and d2 are the distances from the calcula-
tion point to the proximal and distal limits of the heterogene-
ity. This method has also been extended to cases of multiple
heterogeneities.37
2.B. Electrons
The AAPM Task Group 70 (TG70) (Ref. 38) defined the
electron output factor, Se, as
Se(ra, SSD) = D/MU(dm(ra), ra, SSD)
D/MU(dm(r0), r0, SSD0)
= D
′(dm(ra), ra, SSD)
D′0
, (9)
where D/MU is the dose per MU (TG70 notation, D′ in this
report), dm(ra) is the depth of maximum dose for the treatment
field size, ra, and dm(r0) is the depth of maximum dose for the
reference field size, r0. As defined above, the output factor
includes applicator, insert, and treatment distance effects.
2.B.1. Monitor unit equations
2.B.1.a. Electron calculations at standard SSDs. The
equation for MUs for electron beams at the nominal SSD is
given by
MU = D · 100%
D′0 · PDD(d, ra, SSD0) · Se(ra, SSD0)
, (10)
where the PDD is normalized to the depth of maximum dose
for the treatment field size, and Se is the dose output for a
field size (combination of applicator and insert) of ra. The
percentage depth dose term is included to allow for the com-
mon practice of prescribing the dose to a point other than the
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depth of maximum dose along the central axis. Shiu et al.39
found that the PDD is dependent on the insert size, rather than
the applicator size, so we can consider it to be a function of
insert size only if needed. In cases where skin collimation is
used, the output is primarily determined by the applicator and
insert sizes; however, the PDD is primarily determined by the
skin collimation field size.7 Therefore, if skin collimation is
used, the field size used for the PDD term in Eq. (10) should
be the skin collimation field size, rather than the insert and
applicator.
2.B.1.b. Electron calculations at extended SSDs. The
definition of the output factor includes treatment distance ef-
fects; therefore, monitor units can be calculated using Eq. (10)
replacing SSD0 with SSD. However, a more common practice
is to separate field size effects from treatment distance effects.
In other words, the output factor is usually tabulated as a func-
tion of applicator and insert size, ra, at the standard SSD. The
effect of treatment distance not equal to the standard SSD can
be accounted for in two ways, as described in the AAPM Task
Group 25 report.7
2.B.1.b.i. Effective SSD technique.
MU = D · 100%
D′0 · PDD(d, ra, SSD) · Se(ra, SSD0) · ((SSDeff(r) + d0)/(SSDeff(r) + d0 + g))2
, (11)
where g is the difference between the treatment SSD and the calibration SSD, and SSDeff is the effective source to surface
distance for the given field size.
2.B.1.b.ii. Air-gap technique.
MU = D · 100%
D′0 · PDD(d, ra, SSD) · Se(ra, SSD0) · ((SSD0 + d0)/(SSD0 + d0 + g))2 · fair(ra, SSD)
, (12)
where g is the difference between the treatment SSD and the calibration SSD, and fair is the air-gap correction factor for the given
field size and SSD.
2.B.2. Field-size determination
We follow the AAPM TG70 notation in that ra represents
the applicator and insert size for the electron beam under con-
sideration. The vendor-stated applicator size is typically used,
which may be defined at either the isocenter or at the appli-
cator base. In this report, the insert size represents the size
of the electron field incident on the patient, projected to the
isocenter.
For rectangular electron fields, where the insert size is
L × W, the square root (geometric mean) method of Mills
et al.,40 should be utilized
Se(ra, L × W ) = [(Se(ra, L × L)) · (Se(ra,W × W ))]1/2,
(13)
where the same applicator size for all field sizes is implicit.
Shiu et al.,39 found this method to be more accurate than the
equivalent square method of Meyer et al.41
It is also recommended that the square root method be used
to determine PDD for rectangular fields. Shiu et al.39 found
that the square root method determines rectangular field PDD
to within 1%. When applying this method, the depths of max-
imum dose may not be the same for each field size, so a final
renormalization of the geometric mean calculation may be re-
quired.
There are many methods of determining the output factor
for an irregularly shaped electron field. Many centers mea-
sure the output for each irregular field, especially if their use
is infrequent. If the physicist keeps track of the results, then
previously measured data may be used if the energy is the
same and the field shape and size are similar.
A second method of determining the dose output is
through the use of an analytical algorithm, such as the
method described by Khan et al.,42, 43 or a Monte Carlo
code. An example of the latter is given by Kapur et al.44
These types of systems are not in widespread clinical use,
but may become more prevalent in the future. Details of
these approaches are also discussed in the AAPM TG 70
report.38
A third method is to approximate the irregular field
by a rectangle and then use Eq. (13) to calculate the
output of the field. Fundamental principles for determin-
ing equivalent rectangles have been provided by Hogstrom
et al.:45
(a) The equivalent rectangle for the dose output is deter-
mined for the field shape defined by the applicator in-
sert, not by the skin collimator.
(b) The maximum dose output usually occurs in the broad-
est region of the field, i.e., at the point surrounded by
the greatest diameter circle that is enclosed by the field.
(c) The dose output usually varies little beyond some mini-
mum square field size. Hence, areas of the field located
greater than one-half of that distance can be assumed to
contribute insignificantly to the dose output. [According
to Khan et al.42 the minimum radius for lateral scatter
equilibrium is 0.88
√
Ep,0. For example, at 9 MeV, ar-
eas of the field greater than 2.6 cm from the estimated
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FIG. 4. Electron equivalent field sizes. Examples of constructing rectangular fields whose output approximates that of the irregular field for: (a) a posterior
cervical strip; (b) a posterior cervical strip plus submandibular nodes; and (c) an internal mammary chain. The irregular field is delineated by the irregularly
shaped curve. The beam axes are delineated by orthogonal 10 cm line segments. The constructed rectangle is delineated by the four intersecting lines, the center
delineated by “x.” The arcs are a distance 3 cm from the center of the rectangle (Ref. 45).
location for which dose output is being estimated are
insignificant].
(d) The rectangle should be constructed to minimize the
difference in area between it and the irregular field less
any regions ignored. Rotations about the beam central
axis should be used.
(e) The method may not be sufficiently accurate to
be used for highly irregular fields. In such cases,
measurement or other means of calculation are
recommended.45
Figure 4 shows a few clinical examples that illustrate how the
equivalent rectangular field is estimated.
Corrections for rectangular fields that are centered away
from the central axis are rarely needed, especially if beam
flatness is well controlled. In cases where such a correction
is desired, a multiplicative factor (off-axis ratios; OAR) can
be used to account for beam nonuniformity. A major axis
scan measured at a depth near dm for each energy-applicator
combination should be sufficient to estimate OAR values un-
der most conditions. The radial distance from the central axis
should be used, because the scattering foil system is radially
symmetric.
In cases where skin collimation is used, although the elec-
tron percent depth dose is determined by the skin collimation
size,7 the output factor is primarily determined by the appli-
cator and insert sizes.
3. DETERMINATION OF DOSIMETRIC QUANTITIES
In this section, we outline a set of measurements for gen-
erating data sufficient to perform calculations according to
this protocol. The guidelines for relative dosimetry measure-
ments made in the AAPM TG-70 (Ref. 38) and AAPM TG-
106 (Ref. 46) reports should be followed as well.
3.A. Dosimetry equipment
Ionometric measurements are recommended for the major-
ity of measurements described in this protocol. An ionometric
dosimeter system for radiation therapy includes one or more
ionization chamber assemblies, a measuring assembly (elec-
trometer), one or more phantoms with waterproof sleeves, and
one or more stability check devices.47–49
3.A.1. Ionization chambers
Procedures involved in the use of ionization chambers have
been described by a number of reports.7, 47, 48, 50–54 At a min-
imum, the chambers should meet the minimum requirements
described for gathering data necessary for commissioning the
treatment-planning system. These characteristics include, but
are not limited to low leakage (<10 pA), low stem effect
(<0.5%), low angular and polarity dependence (<0.5%), and
high collection efficiency. Details on chamber construction
are available from their respective data sheets provided by
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vendors. For cylindrical chambers, the chamber cavity vol-
ume should be less than 1 cm3. The size is a compromise be-
tween the need for sufficient sensitivity and the ability to mea-
sure dose at a point. For most field sizes, cylindrical chambers
with internal cavity diameter of less than 7 mm and internal
cavity length of less than 25 mm meet these requirements.48
For small field measurements (e.g., ≤3 × 3 cm2), smaller
chambers may be required. Users are referred to the upcom-
ing Task Group 155 report on small field dosimetry.55 During
measurements the chambers should be aligned in such a way
that the radiation fluence is uniform over the cross-section
of the air cavity. For the scanning measurements made to
determine percent depth dose and/or off-axis profiles, it is im-
portant that the chambers be as small as practicable.
Plane-parallel chambers having collection-volume heights
and diameters not exceeding 2 mm and 2.0 cm, respectively,
can be used for relative dose measurements in both photon
and electron beams. Following the recommendation of the
AAPM TG-51 protocol, the point of measurement of a cylin-
drical chamber is taken to lie on the central axis of the cavity
at the center of the active volume of the cavity. For a plane-
parallel chamber, the point of measurement is at the inner sur-
face of the entrance window, at the center of the window, for
all beam qualities and depth. The effective point of measure-
ment for a cylindrical chamber is upstream of the chamber
center (i.e., closer to the radiation source) due to the predom-
inantly forward direction of the secondary electrons (because
the primary beam enters the chamber at various distances up-
stream). Plane-parallel chambers may be designed so that the
chamber samples the electron fluence incident through the
front window, with the contribution of the electrons entering
through the side walls being negligible. This design justifies
taking the effective point of measurement of the chamber to
be at the inner surface of the entrance window, at the center
of the window.7, 48, 54
3.A.2. Phantoms
It is the recommendation of this task group that water be
used as the standard phantom material for the dosimetric mea-
surements of all quantities outlined in this report. The size of
the phantom must be large enough so that there is at least
5 cm of phantom material beyond each side of the radiation
field employed at the depth of measurement and a margin of
at least 10 cm beyond the maximum depth of measurement.
In some cases it is necessary to use solid, nonwater phan-
toms. For example, Sc measurements can be made using a
solid mini-phantom that is thick enough (in the beam direc-
tion) to eliminate electron contamination and small enough
(perpendicular to the beam) to keep the amount of phantom-
scattered photons constant for all measured field sizes. Van
Gasteren et al.,56 described the use of a mini-phantom that
was constructed to best meet these requirements. Ideally, the
solid phantom material should be water equivalent, i.e., it
should have the same electron density and effective atomic
number as water.7 In the event these conditions are not met,
it should be verified that the measured values agree with
those obtained using water or water equivalent solid mini-
phantoms.
3.B. Measurements of dosimetric quantities
In Secs. 3.B.1 and 3.B.2, we describe recommended tech-
niques for determining the dependencies (e.g., field size,
depth, SSD) of dosimetric parameters required by this proto-
col. Typically, users will generate tables of dosimetric quan-
tities produced based on measured set of data for the users
beam. A set of sample data tables are included at the end of
this report.
In general, it is recommended that data be measured such
that variation between any two data points is less than 2%.
Linear or nearest neighbor interpolation may be used to deter-
mine data located between measured results. More advanced
interpolation methods may be used as well, provided the re-
sults are bounded by the neighboring measured data. Extrap-
olation of data beyond that measured is not allowed. If the
field parameters used for the calculation are outside those tab-
ulated, the output should be directly measured by the user.
Additional guidelines for these measurements may be
found in AAPM TG-106 (Ref. 46) and AAPM TG-70
(Ref. 38) reports.
3.B.1. Measurements of dosimetric quantities: Photon
beams
In Secs. 3.B.1 and 3.B.2, we outline a set of commissioning
measurements that may be used to generate the required data
for this protocol.
3.B.1.a. Dose per MU under normalization conditions
(D′0). This protocol requires the knowledge of the linear ac-
celerator’s dose rate or dose per MU, D′0, under normalization
conditions. The normalization conditions are not necessarily
equal to the reference conditions under which the linear accel-
erator is calibrated. For example, although the AAPM TG-51
report6 specifies that the reference depth for photon calibra-
tion is 10 cm, data from the RPC indicates that currently over
90% of monitored clinics perform calculations using a nor-
malization dose rate of 1 cGy/MU at a depth of dm. As stated
in the Introduction, this difference is acceptable within the
current protocol, as long as the normalization depth d0 is at or
beyond the maximum depth of dm.
For a given set of normalization conditions, the choice of
D′0 will be limited to the output range of the linear accelera-
tor. A linear accelerator calibrated to deliver 1 cGy/MU at dm
may require D′0 to be less than 1 cGy/MU at a normalization
depth of 10 cm. For clinics that transition from a normaliza-
tion depth of dm to 10 cm, it may be preferable to select a D′0
value that has a minimal impact on their current linear accel-
erator output. This selection would minimize the change in
calculated MUs for patients currently under treatment. Fur-
thermore, it would allow direct comparison between the old
and new MU calculation systems to verify that the new calcu-
lation methodology was implemented correctly.
As an example consider the transition from a nonisocentric
system that defines D′0 to be 1 cGy/MU at 100 cm SSD and a
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TABLE I. Determination of D′0 for photon beams using 10-cm normalization
depth. For a nonisocentric system with 1 MU defined to deliver 1 cGy at
100 cm SSD and depth = dm, the dose/MU is calculated at the suggested
normalization conditions of d = 10 cm, 100 cm SAD, using depth of dm and
TMR data taken from Ref. 57. The suggested D′0 maintains the definition 1
MU under a new, 10-cm normalization condition.
Energy dm TMR Dose/MU Suggested D′0
(MV) (cm) (10, 10×10)
(
100+dm
100
)2
(cGy/MU) (cGy/MU)
4 1 0.738 1.020 0.753 0.750
5 1.25 0.759 1.025 0.778 0.780
6 1.5 0.786 1.030 0.810 0.810
8 2 0.820 1.040 0.853 0.850
10 2.3 0.839 1.047 0.878 0.880
12 2.6 0.858 1.053 0.903 0.900
15 2.9 0.877 1.059 0.929 0.930
18 3.2 0.896 1.065 0.954 0.950
21 3.5 0.914 1.071 0.979 0.980
25 3.8 0.933 1.077 1.005 1.000
depth of dm, to an isocentric system that defines D′0 at 100 cm
SAD (isocentric), and a depth of 10 cm. In the nonisocen-
tric system, the dose per MU at the normalization point of
the isocentric system is given by TMR(10, 10 × 10) · ((100
+ dm)/100)2. This value will change depending on the energy
of the photon beam. Table I shows the calculated dose per MU
at d0 = 10 cm for a number of different energy photon beams
using data taken from British Journal of Radiology Supple-
ment 25.57 In the last column of the table, D′0 has been set to
this value rounded to the nearest 0.01 cGy/MU, keeping the
difference in beam output less than 1%. If users have multi-
ple machines of the same nominal energy, D′0 could also be
selected to match the average calculated dose per MU of each
of these machines.
3.B.1.b. Normalized percent depth dose. The normal-
ized percent depth dose, PDDN, is defined as the percentage
ratio of the dose rate at depth to the dose rate at the normal-
ization depth in a water phantom. The definition of PDDN is
equivalent to the reference percent depth dose defined in the
European Society for Radiotherapy and Oncology (ESTRO)
report9 and differs from the traditional definition in that the
normalization depth is not necessarily at or near dm. PDDN
is dependent on depth, SSD, and field size on the phantom
surface.
The recommendations of the AAPM TG-51 protocol
should be followed for the measurement of depth dose curves
for photon beams.6 If a cylindrical or spherical ionization
chamber is used, the effective point of measurement of
the chamber must be taken into account. This requires that
the complete depth ionization curve be shifted to shallower
depths (i.e., upstream) by a distance proportional to rcav,
where rcav is the radius of the ionization chamber cavity. For
photon beams, the shift is taken as 0.6 rcav.48 On the other
hand, no shift in depth-ionization curves is needed if well-
guarded plane-parallel ionization chambers are used for the
measurement of photon- or electron-beam depth-ionization
curves.
For photon beams the variation in electron spectra are
small past dm, such that the stopping-power ratio between
water and air is negligible;58 furthermore, the perturbation ef-
fects of the air cavity can be assumed to a reasonable accuracy
to be independent of depth for a given beam quality and field
size. The depth-ionization curve can thus be treated as depth
dose curve for photon beams.
PPDN data should be acquired for a series of field sizes
ranging from the smallest to the largest field to be used clin-
ically. If TPRs are to be calculated from PDDN, the mini-
mum measured field size for PDDN must be smaller than the
minimum field size tabulated for TPRs. The number of mea-
surements should be sufficient such that PDDN varies by less
than 3% between any two measured field sizes. This will re-
quire data more closely spaced for smaller field sizes. Sam-
ple PDDN data (d0 = 10 cm) for a 6 MV beam are given in
Table II.
One could calculate PDDN at different SSDs assuming that
the TPR is independent of the source to point distance.
Substituting fi(d) ≡ (SSDi + d)/SSDi, the following rela-
tionship holds:
PDDN (d, r, SSD2)
PDDN (d, r, SSD1)
= F · TPR(d, r · f2(d))
TPR(d, r · f1(d))
·
[
Sp(r · f1(d0))
Sp(r · f1(d)) ·
Sp(r · f2(d))
Sp(r · f2(d0))
]
,
(14)
where F is the Mayneord F factor59 given by
F =
(
SSD2 + d0
SSD2 + d ·
SSD1 + d
SSD1 + d0
)2
. (15)
Although the magnitude of the term in the brackets in
Eq. (14) increases with depth,60 it is typically small (e.g.,
<0.5%) for all practical clinical setups and can usually be
ignored.
3.B.1.c. Tissue phantom ratios. The TPR is defined as
the ratio of the dose rate at a given point in a water phantom
to the dose rate at the same point at the normalization depth.
TPRs can be measured directly, but may also be calculated
using the following equation:
TPR(d, rd ) =
(
PDDN (d, r, SSD)
100%
)(
SSD + d
SSD + d0
)2
×
(
Sp(rd0 )
Sp(rd )
)
. (16)
TPR is dependent on both the depth and field size at the depth
of measurement. If a reference depth is not beyond the range
of electron contamination, then TPR may also vary with SSD.
If Eq. (16) is used to compute TPRs, spot-check measure-
ments should be made to confirm agreement. In regions of
electronic disequilibrium, Eq. (16) is only approximate,60 al-
though differences between measured and calculated values
are small.
Table III gives sample TPR data (d0 = 10 cm) for a 6 MV
photon beam, calculated using Eq. (16), and the data from
Tables II and IV.
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TABLE II. Normalized percent depth doses (PDDN) (d0 = 10 cm) for 6-MV x-rays, SSD = 100 cm.
Field size 3 × 3 4 × 4 5 × 5 6 × 6 7 × 7 8 × 8 9 × 9 10 × 10 11 × 11 12 × 12 13 × 13 14 × 14 15 × 15 16 × 16 17 × 17
Depth
1.5 164.5 161.8 158.6 155.8 154.0 152.6 151.3 150.1 149.0 148.1 147.4 146.8 146.2 145.6 145.0
2.0 162.0 159.3 156.6 153.7 151.8 150.5 149.2 148.1 146.9 145.9 145.2 144.7 144.2 143.6 143.0
2.5 157.7 155.3 152.6 150.7 148.9 147.3 146.0 144.9 143.9 143.1 142.4 141.8 141.2 140.6 140.1
3.0 153.3 151.1 148.9 146.6 145.1 143.9 142.7 141.6 140.7 139.9 139.3 138.8 138.3 137.8 137.3
3.5 148.6 147.0 145.1 143.1 141.8 140.7 139.5 138.4 137.5 136.8 136.3 135.9 135.5 135.0 134.5
4.0 144.6 142.9 141.5 139.3 138.0 137.2 136.3 135.4 134.7 134.0 133.5 133.0 132.6 132.2 131.8
4.5 140.4 139.0 137.7 135.9 134.8 134.0 133.1 132.3 131.7 131.1 130.6 130.2 129.8 129.4 129.0
5.0 136.4 135.3 134.0 132.5 131.5 130.7 130.0 129.3 128.7 128.2 127.8 127.5 127.2 126.8 126.4
5.5 132.2 131.5 130.3 129.0 128.2 127.6 126.9 126.3 125.7 125.1 124.8 124.5 124.3 124.0 123.6
6.0 128.3 127.7 126.6 125.5 124.9 124.4 123.8 123.2 122.7 122.3 122.0 121.8 121.6 121.3 121.0
6.5 124.4 124.0 123.1 122.1 121.6 121.3 120.6 120.0 119.6 119.3 119.1 118.9 118.8 118.6 118.3
7.0 120.5 120.3 119.3 118.7 118.3 118.0 117.5 117.0 116.7 116.5 116.2 116.0 115.7 115.5 115.3
7.5 116.8 116.8 115.8 115.3 114.9 114.5 114.2 113.9 113.7 113.5 113.3 113.2 113.0 112.9 112.7
8.0 113.4 113.2 112.5 112.1 111.8 111.6 111.2 110.9 110.7 110.5 110.4 110.3 110.3 110.2 110.1
8.5 109.6 110.0 109.1 108.9 108.8 108.7 108.4 108.0 107.9 107.8 107.8 107.7 107.7 107.6 107.5
9.0 106.1 106.6 106.0 105.8 105.7 105.7 105.5 105.3 105.3 105.3 105.2 105.2 105.1 105.1 105.0
9.5 102.9 103.2 102.7 102.9 102.9 102.8 102.6 102.5 102.5 102.6 102.6 102.5 102.5 102.5 102.5
10.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0
10.5 96.9 97.2 97.0 97.2 97.3 97.4 97.4 97.4 97.5 97.6 97.7 97.7 97.7 97.7 97.7
11.0 94.0 94.4 94.2 94.4 94.6 94.7 94.8 94.8 94.8 94.9 95.0 95.2 95.3 95.4 95.4
11.5 91.1 91.6 91.5 91.7 91.9 92.1 92.2 92.3 92.4 92.6 92.7 92.8 92.9 93.0 93.0
12.0 88.4 88.9 88.7 89.0 89.2 89.4 89.6 89.8 90.0 90.2 90.4 90.5 90.6 90.7 90.7
12.5 85.5 86.0 85.9 86.3 86.6 86.9 87.0 87.2 87.5 87.8 87.9 88.0 88.0 88.1 88.3
13.0 83.4 83.3 83.3 83.7 84.1 84.4 84.5 84.7 85.0 85.4 85.6 85.7 85.8 85.9 86.1
13.5 80.4 80.8 80.7 81.3 81.8 82.1 82.3 82.5 82.8 83.1 83.3 83.5 83.7 83.9 84.0
14.0 77.8 78.5 78.4 79.0 79.5 79.8 79.9 80.1 80.5 80.9 81.2 81.5 81.7 81.9 82.0
14.5 75.4 76.1 76.2 76.7 77.1 77.5 77.8 78.1 78.5 78.9 79.2 79.5 79.7 79.9 80.0
15.0 73.3 73.8 74.0 74.5 75.0 75.4 75.6 75.9 76.3 76.8 77.1 77.4 77.6 77.8 78.0
16.0 69.1 69.7 69.8 70.6 71.1 71.4 71.6 71.9 72.4 72.9 73.2 73.4 73.6 73.9 74.1
17.0 64.9 65.5 65.7 66.4 67.0 67.5 67.8 68.0 68.5 69.0 69.3 69.6 69.9 70.2 70.4
18.0 61.1 61.6 61.8 62.6 63.2 63.6 63.9 64.2 64.8 65.4 65.8 66.1 66.3 66.6 66.8
19.0 57.5 58.1 58.2 59.0 59.5 59.9 60.3 60.8 61.4 61.9 62.3 62.6 62.9 63.2 63.5
20.0 54.1 54.8 55.0 55.8 56.4 56.9 57.2 57.6 58.2 58.8 59.1 59.4 59.6 59.9 60.2
21.0 51.2 51.6 51.9 52.8 53.4 53.9 54.2 54.5 55.0 55.6 56.0 56.4 56.7 57.0 57.3
22.0 48.2 48.7 48.8 49.9 50.5 50.9 51.2 51.5 52.2 52.9 53.3 53.5 53.7 54.0 54.2
23.0 45.4 46.1 46.0 46.9 47.6 48.2 48.4 48.6 49.3 50.0 50.4 50.7 50.9 51.2 51.5
24.0 42.8 43.5 43.4 44.2 44.9 45.4 45.7 46.0 46.6 47.3 47.7 48.0 48.2 48.5 48.8
25.0 40.3 41.1 41.0 42.0 42.6 43.0 43.2 43.5 44.2 44.9 45.3 45.6 45.8 46.1 46.4
Field size 18 × 18 19 × 19 20 × 20 21 × 21 22 × 22 24 × 24 26 × 26 28 × 28 30 × 30 32 × 32 34 × 34 36 × 36 38 × 38 40 × 40
Depth
1.5 144.4 143.9 143.4 143.0 142.5 141.8 141.2 140.8 140.4 140.0 139.6 139.3 139.0 138.7
2.0 142.4 141.8 141.3 140.8 140.4 139.7 139.2 138.8 138.5 138.1 137.8 137.5 137.1 136.8
2.5 139.6 139.1 138.7 138.3 137.8 137.1 136.6 136.3 136.0 135.7 135.4 135.1 134.8 134.5
3.0 136.9 136.4 136.0 135.6 135.2 134.6 134.1 133.6 133.3 133.0 132.7 132.5 132.3 132.1
3.5 134.1 133.6 133.2 132.8 132.5 131.9 131.5 131.2 130.9 130.6 130.4 130.1 129.9 129.7
4.0 131.4 131.0 130.7 130.4 130.1 129.5 129.1 128.8 128.5 128.2 128.0 127.8 127.6 127.5
4.5 128.7 128.3 128.0 127.7 127.4 126.9 126.6 126.3 126.1 125.9 125.6 125.4 125.2 125.0
5.0 126.1 125.7 125.4 125.1 124.9 124.5 124.2 124.0 123.8 123.6 123.4 123.1 122.9 122.6
5.5 123.3 123.0 122.7 122.5 122.3 122.0 121.7 121.5 121.2 121.0 120.8 120.6 120.5 120.4
6.0 120.8 120.5 120.2 120.0 119.7 119.4 119.1 118.9 118.8 118.6 118.5 118.3 118.2 118.0
6.5 118.1 117.8 117.6 117.4 117.2 116.9 116.7 116.5 116.3 116.1 116.0 115.9 115.8 115.7
7.0 115.2 115.0 114.9 114.8 114.6 114.4 114.2 114.1 114.0 113.9 113.8 113.6 113.5 113.4
7.5 112.6 112.4 112.3 112.1 112.0 111.7 111.5 111.4 111.3 111.2 111.1 111.1 111.0 111.0
8.0 109.9 109.8 109.7 109.6 109.5 109.4 109.2 109.0 108.8 108.7 108.6 108.6 108.6 108.7
8.5 107.4 107.2 107.1 107.0 107.0 106.8 106.8 106.7 106.6 106.5 106.5 106.4 106.4 106.4
9.0 105.0 104.9 104.9 104.8 104.7 104.6 104.5 104.4 104.4 104.4 104.3 104.3 104.2 104.2
9.5 102.4 102.4 102.4 102.4 102.3 102.2 102.2 102.2 102.3 102.3 102.3 102.2 102.2 102.1
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TABLE II. (Continued.)
Field size 18 × 18 19 × 19 20 × 20 21 × 21 22 × 22 24 × 24 26 × 26 28 × 28 30 × 30 32 × 32 34 × 34 36 × 36 38 × 38 40 × 40
Depth
10.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0 100.0
10.5 97.7 97.7 97.7 97.7 97.7 97.7 97.7 97.8 97.8 97.8 97.9 97.9 98.0 98.0
11.0 95.5 95.5 95.5 95.5 95.5 95.5 95.5 95.6 95.7 95.8 95.8 95.8 95.8 95.8
11.5 93.1 93.1 93.2 93.3 93.3 93.5 93.5 93.5 93.5 93.5 93.6 93.6 93.7 93.8
12.0 90.7 90.8 90.8 90.9 91.0 91.2 91.3 91.3 91.3 91.3 91.4 91.4 91.5 91.6
12.5 88.4 88.5 88.7 88.8 88.9 89.1 89.2 89.3 89.3 89.3 89.4 89.5 89.5 89.6
13.0 86.2 86.3 86.4 86.5 86.6 86.8 87.0 87.1 87.2 87.3 87.4 87.5 87.5 87.6
13.5 84.1 84.3 84.4 84.6 84.7 85.0 85.1 85.2 85.2 85.3 85.4 85.5 85.6 85.7
14.0 82.2 82.3 82.4 82.5 82.6 82.8 83.0 83.2 83.3 83.4 83.6 83.7 83.8 83.9
14.5 80.2 80.3 80.4 80.5 80.7 80.9 81.1 81.2 81.3 81.4 81.6 81.7 81.8 82.0
15.0 78.2 78.3 78.5 78.7 78.8 79.1 79.3 79.5 79.6 79.7 79.9 80.0 80.1 80.2
16.0 74.3 74.6 74.8 75.0 75.2 75.6 75.8 75.9 76.0 76.1 76.3 76.4 76.6 76.8
17.0 70.7 70.9 71.1 71.3 71.6 71.9 72.2 72.3 72.4 72.5 72.7 72.8 73.0 73.2
18.0 67.0 67.3 67.5 67.8 68.0 68.4 68.7 68.9 69.0 69.2 69.3 69.5 69.7 69.9
19.0 63.7 64.0 64.2 64.5 64.7 65.1 65.4 65.6 65.8 66.0 66.2 66.4 66.6 66.8
20.0 60.5 60.8 61.1 61.4 61.6 62.1 62.4 62.7 62.9 63.1 63.3 63.5 63.7 63.8
21.0 57.5 57.8 58.0 58.3 58.6 59.2 59.5 59.8 59.9 60.1 60.3 60.5 60.7 60.9
22.0 54.5 54.8 55.1 55.4 55.8 56.3 56.7 56.9 57.0 57.2 57.4 57.6 57.8 58.1
23.0 51.7 52.0 52.3 52.6 53.0 53.5 53.9 54.1 54.2 54.4 54.6 54.9 55.1 55.4
24.0 49.1 49.4 49.7 50.0 50.4 50.9 51.3 51.5 51.6 51.8 52.0 52.2 52.4 52.7
25.0 46.7 47.0 47.3 47.7 48.0 48.6 49.0 49.1 49.2 49.4 49.6 49.8 50.1 50.4
TABLE III. Tissue phantom ratios (TPRs) for 6-MV photons (d0 = 10 cm).
Field size 4 × 4 5 × 5 6 × 6 7 × 7 8 × 8 9 × 9 10 × 10 11 × 11 12 × 12 13 × 13 14 × 14 15 × 15 16 × 16 17 × 17
Depth
1.5 1.390 1.364 1.340 1.323 1.313 1.302 1.291 1.281 1.273 1.267 1.261 1.256 1.251 1.246
2.0 1.381 1.360 1.336 1.317 1.307 1.296 1.286 1.275 1.267 1.260 1.255 1.251 1.246 1.241
2.5 1.360 1.338 1.321 1.305 1.292 1.281 1.270 1.261 1.254 1.247 1.241 1.237 1.232 1.228
3.0 1.335 1.318 1.298 1.283 1.273 1.263 1.253 1.244 1.238 1.232 1.227 1.223 1.219 1.214
3.5 1.311 1.296 1.279 1.266 1.257 1.247 1.237 1.228 1.221 1.216 1.212 1.209 1.205 1.201
4.0 1.286 1.275 1.258 1.244 1.236 1.229 1.221 1.213 1.208 1.202 1.198 1.194 1.191 1.187
4.5 1.263 1.252 1.238 1.226 1.219 1.212 1.204 1.197 1.192 1.188 1.183 1.180 1.177 1.173
5.0 1.240 1.230 1.217 1.207 1.200 1.193 1.187 1.181 1.177 1.172 1.169 1.167 1.164 1.161
5.5 1.216 1.207 1.196 1.187 1.181 1.176 1.170 1.164 1.159 1.155 1.152 1.150 1.148 1.145
6.0 1.192 1.183 1.174 1.166 1.162 1.157 1.152 1.147 1.143 1.139 1.137 1.135 1.133 1.131
6.5 1.167 1.161 1.152 1.146 1.143 1.139 1.133 1.127 1.124 1.122 1.120 1.119 1.117 1.115
7.0 1.142 1.135 1.129 1.125 1.122 1.118 1.114 1.110 1.107 1.105 1.103 1.100 1.098 1.096
7.5 1.119 1.112 1.106 1.102 1.098 1.095 1.092 1.090 1.088 1.086 1.085 1.083 1.082 1.081
8.0 1.094 1.089 1.084 1.082 1.079 1.077 1.074 1.071 1.069 1.067 1.066 1.066 1.065 1.065
8.5 1.072 1.067 1.062 1.061 1.060 1.058 1.055 1.052 1.051 1.050 1.050 1.050 1.049 1.049
9.0 1.047 1.045 1.041 1.040 1.039 1.038 1.037 1.035 1.035 1.035 1.034 1.034 1.033 1.033
9.5 1.023 1.020 1.019 1.020 1.020 1.019 1.017 1.016 1.017 1.017 1.017 1.017 1.016 1.016
10.0 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000
10.5 0.980 0.979 0.979 0.981 0.982 0.982 0.982 0.982 0.983 0.984 0.985 0.985 0.985 0.985
11.0 0.960 0.959 0.959 0.961 0.962 0.963 0.964 0.964 0.965 0.965 0.966 0.967 0.969 0.970
11.5 0.939 0.940 0.939 0.941 0.943 0.945 0.946 0.947 0.948 0.950 0.951 0.952 0.953 0.953
12.0 0.919 0.919 0.918 0.921 0.923 0.925 0.927 0.929 0.931 0.933 0.934 0.936 0.937 0.938
12.5 0.896 0.897 0.897 0.901 0.904 0.906 0.908 0.909 0.912 0.915 0.917 0.918 0.918 0.918
13.0 0.877 0.876 0.877 0.882 0.885 0.888 0.889 0.891 0.893 0.897 0.900 0.901 0.902 0.903
13.5 0.856 0.857 0.858 0.863 0.868 0.870 0.873 0.875 0.877 0.880 0.883 0.885 0.887 0.888
14.0 0.838 0.840 0.840 0.846 0.850 0.853 0.855 0.856 0.859 0.863 0.867 0.870 0.872 0.874
14.5 0.818 0.822 0.823 0.828 0.832 0.835 0.838 0.841 0.845 0.848 0.852 0.855 0.857 0.860
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TABLE III. (Continued.)
Field size 4 × 4 5 × 5 6 × 6 7 × 7 8 × 8 9 × 9 10 × 10 11 × 11 12 × 12 13 × 13 14 × 14 15 × 15 16 × 16 17 × 17
Depth
15.0 0.801 0.804 0.806 0.811 0.815 0.819 0.822 0.824 0.828 0.832 0.836 0.839 0.842 0.844
16.0 0.768 0.771 0.773 0.781 0.785 0.788 0.791 0.793 0.797 0.802 0.806 0.809 0.811 0.813
17.0 0.733 0.737 0.739 0.746 0.752 0.756 0.760 0.762 0.766 0.770 0.775 0.779 0.782 0.784
18.0 0.701 0.704 0.706 0.714 0.720 0.724 0.727 0.731 0.735 0.740 0.746 0.750 0.753 0.756
19.0 0.671 0.675 0.675 0.683 0.689 0.693 0.697 0.701 0.706 0.712 0.717 0.722 0.725 0.728
20.0 0.642 0.647 0.648 0.656 0.663 0.667 0.672 0.675 0.679 0.685 0.691 0.696 0.698 0.701
21.0 0.616 0.619 0.621 0.630 0.637 0.642 0.646 0.649 0.653 0.657 0.663 0.668 0.672 0.676
22.0 0.590 0.593 0.593 0.603 0.612 0.616 0.619 0.622 0.626 0.632 0.639 0.645 0.648 0.651
23.0 0.565 0.570 0.568 0.575 0.585 0.590 0.595 0.597 0.600 0.605 0.612 0.619 0.623 0.626
24.0 0.541 0.546 0.544 0.550 0.559 0.564 0.569 0.572 0.576 0.581 0.588 0.594 0.598 0.601
25.0 0.517 0.524 0.522 0.529 0.539 0.543 0.547 0.550 0.553 0.558 0.565 0.572 0.576 0.579
Field size 18 × 18 19 × 19 20 × 20 21 × 21 22 × 22 24 × 24 26 × 26 28 × 28 30 × 30 32 × 32 34 × 34 36 × 36 38 × 38 40 × 40
Depth
1.5 1.241 1.237 1.232 1.228 1.224 1.218 1.212 1.207 1.204 1.200 1.196 1.192 1.189 1.186
2.0 1.236 1.231 1.226 1.222 1.218 1.211 1.205 1.201 1.199 1.195 1.192 1.188 1.185 1.181
2.5 1.223 1.219 1.215 1.211 1.207 1.200 1.194 1.190 1.188 1.185 1.182 1.179 1.176 1.173
3.0 1.210 1.206 1.203 1.199 1.195 1.189 1.184 1.179 1.176 1.173 1.170 1.167 1.164 1.162
3.5 1.197 1.193 1.189 1.186 1.182 1.177 1.172 1.168 1.166 1.163 1.160 1.157 1.155 1.152
4.0 1.184 1.181 1.177 1.174 1.171 1.166 1.161 1.158 1.155 1.152 1.150 1.148 1.145 1.143
4.5 1.170 1.167 1.164 1.161 1.158 1.153 1.149 1.146 1.144 1.142 1.139 1.137 1.135 1.132
5.0 1.157 1.154 1.151 1.148 1.145 1.141 1.138 1.135 1.133 1.131 1.129 1.127 1.124 1.122
5.5 1.142 1.139 1.136 1.134 1.132 1.129 1.126 1.123 1.120 1.118 1.116 1.114 1.112 1.111
6.0 1.128 1.126 1.123 1.121 1.118 1.115 1.111 1.109 1.107 1.106 1.104 1.103 1.101 1.099
6.5 1.113 1.111 1.109 1.107 1.105 1.102 1.099 1.096 1.094 1.093 1.091 1.090 1.088 1.087
7.0 1.094 1.093 1.092 1.091 1.089 1.087 1.085 1.083 1.082 1.081 1.080 1.078 1.077 1.076
7.5 1.079 1.078 1.077 1.076 1.074 1.072 1.069 1.067 1.066 1.065 1.064 1.063 1.062 1.062
8.0 1.063 1.062 1.061 1.060 1.059 1.058 1.056 1.054 1.052 1.051 1.049 1.048 1.048 1.048
8.5 1.048 1.047 1.045 1.044 1.043 1.042 1.041 1.040 1.039 1.038 1.038 1.037 1.037 1.036
9.0 1.032 1.032 1.032 1.031 1.031 1.029 1.028 1.027 1.026 1.026 1.026 1.025 1.025 1.024
9.5 1.016 1.016 1.016 1.015 1.015 1.014 1.014 1.013 1.013 1.014 1.014 1.014 1.014 1.013
10.0 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000
10.5 0.986 0.986 0.986 0.986 0.985 0.985 0.985 0.986 0.986 0.986 0.987 0.987 0.988 0.988
11.0 0.970 0.971 0.971 0.971 0.972 0.972 0.972 0.972 0.973 0.973 0.974 0.975 0.975 0.975
11.5 0.954 0.955 0.955 0.956 0.956 0.957 0.959 0.960 0.960 0.960 0.960 0.960 0.961 0.961
12.0 0.938 0.938 0.939 0.939 0.940 0.941 0.943 0.945 0.945 0.945 0.945 0.946 0.946 0.947
12.5 0.920 0.921 0.922 0.924 0.925 0.927 0.929 0.931 0.932 0.932 0.933 0.933 0.934 0.935
13.0 0.904 0.905 0.906 0.908 0.909 0.911 0.913 0.915 0.916 0.917 0.918 0.920 0.921 0.922
13.5 0.890 0.891 0.892 0.894 0.895 0.898 0.901 0.903 0.904 0.905 0.905 0.906 0.907 0.908
14.0 0.876 0.877 0.879 0.880 0.881 0.883 0.885 0.887 0.889 0.891 0.892 0.894 0.895 0.897
14.5 0.861 0.863 0.864 0.866 0.867 0.869 0.872 0.874 0.876 0.877 0.878 0.880 0.881 0.883
15.0 0.846 0.848 0.849 0.851 0.853 0.856 0.859 0.862 0.864 0.865 0.867 0.868 0.870 0.871
16.0 0.815 0.818 0.820 0.822 0.825 0.829 0.833 0.837 0.839 0.840 0.842 0.843 0.845 0.846
17.0 0.787 0.789 0.792 0.794 0.796 0.801 0.805 0.809 0.812 0.814 0.815 0.816 0.818 0.820
18.0 0.758 0.761 0.763 0.765 0.768 0.773 0.777 0.782 0.786 0.787 0.789 0.791 0.793 0.795
19.0 0.730 0.733 0.736 0.739 0.741 0.746 0.751 0.756 0.760 0.762 0.764 0.766 0.769 0.771
20.0 0.703 0.706 0.709 0.712 0.715 0.721 0.727 0.732 0.736 0.739 0.742 0.744 0.747 0.749
21.0 0.679 0.682 0.685 0.687 0.690 0.695 0.701 0.707 0.713 0.716 0.718 0.720 0.722 0.725
22.0 0.653 0.655 0.658 0.661 0.664 0.670 0.677 0.683 0.689 0.692 0.694 0.696 0.698 0.700
23.0 0.628 0.631 0.634 0.636 0.639 0.645 0.652 0.659 0.665 0.668 0.670 0.672 0.674 0.676
24.0 0.603 0.606 0.609 0.612 0.615 0.622 0.629 0.636 0.642 0.646 0.648 0.650 0.651 0.654
25.0 0.582 0.584 0.587 0.591 0.594 0.600 0.607 0.615 0.621 0.626 0.628 0.629 0.630 0.633
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TABLE IV. Scatter correction factors for 6-MV x-rays (d0 = 10 cm).
Field size Total scatter In-air output Phantom scatter
Equivalent correction factor ratio factor
square A/P Sc,p Sc Sp
4.0 1.0 0.866 0.957 0.905
5.0 1.25 0.895 0.968 0.925
6.0 1.5 0.922 0.977 0.944
8.0 2.0 0.964 0.990 0.974
10.0 2.5 1.000 1.000 1.000
12.0 3.0 1.028 1.008 1.020
14.0 3.5 1.051 1.014 1.037
16.0 4.0 1.070 1.018 1.051
20.0 5.0 1.102 1.024 1.076
24.0 6.0 1.127 1.029 1.096
28.0 7.0 1.149 1.034 1.111
32.0 8.0 1.167 1.040 1.123
40.0 10.0 1.194 1.048 1.139
3.B.1.d. Sc. Sc is the ratio of in-air radiation output for a
given collimator setting to that for a collimator setting of 10
× 10 cm2.10 Figure 5 diagrams a typical measurement setup,
for a ion chamber placed in a mini-phantom at the isocenter.
Sc is measured for different square collimator settings rang-
ing over all clinically used field sizes. It is recommended that
a sufficient number of field sizes be measured such that Sc
changes by less than ∼1% between consecutive measured col-
limator settings. The magnitude of the collimator exchange
effect for large, clinically relevant aspect ratios (e.g., 5 × 40
and 40 × 5 cm2) should be determined and the accuracy of
the algorithm in predicting the output for these field shapes
should be verified. For these field sizes, users should account
for the stem effect in the measurement results.
The effective thickness of buildup material along the di-
rection of the radiation beam has been discussed in sev-
eral reports.10, 61–64 The thickness of material perpendicular
to the beam direction should provide enough lateral scatter65
Mini-phantom
FIG. 5. Diagram illustrating measurement setup for Sc. The cylindrical mini-
phantom is aligned coaxially with the central axis of the beam, with the ion
chamber positioned at the source-detector distance corresponding to the cho-
sen normalization conditions. The field size is maintained large enough to
ensure coverage of the mini-phantom, and other scattering materials are re-
moved from the treatment field.
so that the accuracy of the measured Sc is maintained. This
task group recommends a 4-cm diameter cylindrical mini-
phantom56 coaxial with the central axis of the beam with the
detector at 10-cm depth for the measurement of Sc indepen-
dent of the normalization depth. It is pointed out in the report
of the AAPM Therapy Physics Committee TG 74 (Ref. 10)
that it is more accurate for calculations beyond the range of
contamination electrons to use Sc measured at 10 cm. Water-
equivalent materials are recommended for the construction of
the mini-phantom, given reports of some variation in results
using high Z build-up materials.65 However, for field sizes be-
tween 1 and 5 cm, a high Z mini-phantom can be used as
long as the Sc is renormalized so that the Sc measured at 5 cm
field size matches that measured with a water equivalent mini-
phantom, as described in the TG-74 report.10
Sc should be measured with the detector at the isocenter
unless the field size for the measurement does not encom-
pass the whole phantom. Care should be taken to minimize
the amount of scattered radiation from structures close to the
detector, such as support stands, the floor, the wall, or the ta-
ble. A Styrofoam stand can be used to support the detector
away from any backscattering material. It is recommended
that the measurements be made with the beam pointing at the
wall instead of the floor to reduce scattered radiation. This ir-
radiation configuration also allows the alignment of the axis
of the mini-phantom with the central axis of the beam using
lasers and crosshair. The detector should be checked for stem
and cable effects, especially for fields with large aspect ratios.
In order to commission the calculation algorithm based
on the point’s-eye-view of the treatment head, the distances
of the proximal surface of all collimators from the target along
the direction of the central axis should be either obtained from
the manufacturer or measured.
Table IV gives Sc data for a 6-MV photon beam with a
normalization depth of 10 cm.
3.B.1.e. Sp. Sp is defined as the ratio of the dose rate at
the normalization depth for a given field size in a water phan-
tom to that of the reference field size for the same incident
energy fluence. Sp can be computed as a function of the field
size at the irradiated volume from the measured quantities Scp
and Sc,
Sp(r) =
(
Sc,p(r)
Sc(r)
)
. (17)
Scp is measured in a water phantom at SSD0 with the detec-
tor at d0 for different collimator settings. For the same d0,
Sp should display little to no variation between linear accel-
erators with the same beam quality, so that comparisons be-
tween different machines and/or with published results66 may
be useful in verifying results of a specific machine.
Table IV displays sample Sp data for a 6 MV photon beam
for a normalization depth of 10 cm. In contrast to the data for
Sc, these data exhibit a much greater dependence on the depth
of normalization.
3.B.1.f. Off-axis ratios. In this protocol, MU calcula-
tions to off-axis points are made using central axis dosimet-
ric quantities (e.g., Scp, TPR), with an open-field off-axis ra-
tio, OAR. Although there are circumstances where off-axis
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calculations are preferred (e.g., when the central axis is
blocked or in regions of electronic disequilibrium), this task
group recommends that every attempt be made to keep this
calculation on the central axis to avoid the complications as-
sociated with off-axis calculations.
Several methods have been proposed for the determination
of OAR for MU calculation. Early recommendations were
to equate OAR with large field central axis profile data.67, 68
However, measured profile data inherently contain changes in
the relative scatter contribution within the phantom which are
not accounted for in the current formalism.69 Although good
agreement is obtained for points close to the central axis,67, 70
errors greater than 5% can be obtained using profile data close
to the edge of the field (e.g., x > 10 cm). Although calcula-
tions to points this far off-axis are unlikely to be seen in the
clinic with any frequency, caution should be used when using
these data for OAR.
Better agreement has been found equating OAR to the pri-
mary off-axis ratio, POAR. This quantity represents the ratio
of doses due only to primary (unscattered) photons. POARs
may be obtained either by extraction from large-field central
axis profiles or by direct measurement. Unlike large-field pro-
file data, POARs will not decrease near the field edge due
to reduced scatter. Chui et al.71 proposed determining POAR
by measuring profiles at extended distances, where the scat-
ter contributions to the projected off-axis points have equili-
brated. In their work, profile data were measured at various
depths on the floor using film dosimetry.
Gibbons and Khan70 measured transmitted dose pro-
files through different thicknesses of absorbers under “good
geometry” conditions (narrow beam and large detector-to-
absorber distance). In this method, the beam is collimated us-
ing asymmetric fields or MLCs to define small fields (e.g., 2
× 2 cm2) on-axis and at off-axis positions. POARs are cal-
culated using the ratio of in-air ion chamber readings (with
appropriate buildup) at large distances from the source to min-
imize scatter. Plastic absorbers are placed near the collimating
jaws to determine the depth dependence of these ratios.
Finally, there are independent analytic formalisms that re-
move the scatter component from measured commissioning
data.70, 72–74 Additionally, depending on the planning system
it may be possible to extract the primary energy fluence trans-
mitted through a flat water phantom to determine POAR. In
either case, it is recommended that a few sample measure-
ments be made to confirm these data. This can be easily
performed by measuring the dose per MU for some simple
off-axis fields.
It is the recommendation of the task group that primary
off-axis profiles be used for OARs. Typically, these data do
not change rapidly with off-axis distance or depth, and inter-
polation between a few points will provide sufficient accu-
racy. An example dataset is shown in Table V, which dis-
plays sample POAR data for a 6-MV photon beam. These
OAR data were taken from the “primary profile” data of the
Theraplan treatment-planning system, originating from mea-
sured large field profiles.75 The radial distance from the cen-
tral axis should be used, because the flattening filter is radially
symmetric.
TABLE V. Open field off-axis ratios for 6-MV x-rays. Sample data from a
Varian Clinac 2100C accelerator.
OADa
(cm) 0 2 4 6 8 10 15 18
Depth (cm) 1.5 1.000 1.006 1.022 1.030 1.034 1.043 1.055 1.058
3.0 1.000 1.011 1.027 1.033 1.040 1.045 1.056 1.058
5 1.000 1.017 1.033 1.041 1.046 1.048 1.058 1.057
8 1.000 1.011 1.030 1.036 1.040 1.043 1.050 1.051
10 1.000 1.006 1.028 1.030 1.031 1.031 1.033 1.032
12 1.000 1.006 1.023 1.028 1.029 1.026 1.026 1.026
15 1.000 1.007 1.016 1.025 1.025 1.018 1.016 1.016
aRadial off axis distances projected on a plane at 100 cm from source.
3.B.1.g. Tray factors (TF). TF is defined as the ratio of
the dose rate at the point of calculation for a given field with
and without a blocking tray in place. TF is almost indepen-
dent of field size, depth, and SSD, and a constant value is
sufficient in most cases. The presence of the tray will affect
the dose in the build-up region through the production of sec-
ondary electrons as well as the absorption of secondary elec-
trons produced upstream of the tray. Thus, it is recommended
that this factor be measured at a depth well beyond the maxi-
mum range of electron contamination. The TF may also be
used to account for attenuation due to other devices, such
as additional trays, beam spoilers, or special patient support
devices.
3.B.1.h. Compensators. Unlike blocking trays, compen-
sators are specifically designed to affect the dose per MU
within the field and often have a more significant impact
on the MU calculation. In addition, the presence of a com-
pensator mounting tray must be included in the calculation.
The calculation is most significantly affected by the thickness
of the compensating filter placed directly over the point of
calculation.
Ideally, compensators are designed such that no compen-
sating material is placed directly over the point of calculation
and no correction is required. Otherwise, compensators may
be included within the calculation in a couple of ways. First,
the compensator may be included in the TF, which represents
the ratio of doses to the point of calculation with and with-
out the compensator for a given number of monitor units. For
a compensator of a given thickness, the amount of attenua-
tion depends on a variety of parameters including beam en-
ergy, compensator-to-patient surface distance, field size, and
depth.76 These dependencies are usually slowly varying, al-
though larger variations have been noted for regions near
highly sloped surfaces or within or near the buildup region.77
For a given geometry and beam quality, however, the compen-
sator effect can be approximated as being dependent only on
the amount of compensating material placed directly above
the point of calculation. The net effect can be determined
either by direct measurement, or approximated by effective
(broad-beam) linear attenuation coefficients. If simple step-
wedge compensators are fabricated using a combination of
a number of individually positioned sheets, one may create
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a table of attenuation factors as a function of the number of
sheets. As in the case of blocking trays, the attenuation factors
should be measured at a depth beyond the range of contami-
nant electrons, e.g., at the normalization depth.
An alternative approach is to treat the compensator as re-
placing tissue deficit.27 In this approach, there is no modifi-
cation of the attenuation factor, and the beam attenuation is
accounted for by the increased effective depth of the point of
calculation. The amount of missing tissue “replaced” by the
compensator is determined by scaling the tissue deficit by the
ratio τ /ρe, where τ is a unitless factor that accounts for the
resulting loss of scatter due to the compensator’s placement
in the collimator head, and ρe is the electron density (relative
to water) of the compensating filter material. Details of this
approach have been published in Ref. 27.
3.B.1.i. Wedge factors. The wedge factor WF is defined
as the ratio of the dose rate at the point of calculation for a
wedged field to that for the same field without a wedge mod-
ifier. Although the presence of the wedge will affect several
other dosimetric quantities, within this protocol, all these ef-
fects are incorporated into the WF. This approach eliminates
the need for separate wedge-field data tables, but may require
field size and depth dependent wedge factors.
Since wedge field isodose plans are calculated using a
treatment-planning system, it is important that the physicist
fully understands how field weights are handled in the pres-
ence of a wedge. In some cases it is possible to mistakenly ap-
ply a “double-wedge factor.” This occurs when the treatment-
planning computer assigns a beam weight that builds in the
wedge transmission factor, and the physicist in turn uses this
filtered weight to calculate monitor units, and then once again
accounts for the wedge factor. Additional considerations are
discussed in Secs. 5 and 7.
3.B.1.i.i. Physical wedges. A number of investigators
have studied the field size and depth dependence of internal
and external WFs. The field size dependency appears to origi-
nate from a wedge-induced increase in collimator scatter.28, 78
Heukelom et al.78 accurately predicted the field-size depen-
dence of internal wedges, which demonstrate a larger vari-
ation with field size. A field-size dependence may also be
necessary for external wedges, particularly for higher wedge
angles.79
The depth dependence of WF has been attributed both
to beam hardening as well as “dose-gradient” effects, i.e.,
changes in depth dose due to the dose gradient across the
field.80 McCullough et al.81 demonstrated that for depths less
than 10 cm, an error of less than 2% is made if this quantity
is ignored. Nevertheless, the increased use of wedged fields
for depths beyond 10 cm has necessitated the inclusion of this
dependency in clinical calculations.79
It is the recommendation of this task group that physical
wedge factors be measured as a function of both field size
and depth. With the chamber axis perpendicular to the gradi-
ent direction of the wedge, two sets of measurements should
be made with the wedge in opposite orientations to accommo-
date uncertainties in the chamber position and wedge mount-
ing. It is recommended that measurements be made with the
chamber at the isocenter. An example dataset of measured
physical wedge factor for a 6 MV photon beam is shown in
Table VI.
In this report, these data are considered independent of
SSD. However, for treatments at extended distances (e.g.,
SSD > 120 cm), it would be prudent to confirm the accu-
racy of the wedge factor determined at isocenter, as investi-
gators have noted a slight dependence on SSD.82, 83 For these
calculations, it is also necessary to account for the field size
TABLE VI. Physical wedge factors for 6-MV x-rays. Sample data for a Varian Clinac 2100C accelerator.
15◦ 30◦
Depth
Side of equivalent square (cm)
Depth
Side of equivalent square (cm)
(cm) 5 10 15 20 30 (cm) 5 10 15 20 30
1.5 0.696 0.707 0.714 0.720 0.752 1.5 0.531 0.539 0.553 0.567 0.578
5.0 0.697 0.709 0.715 0.721 0.738 5.0 0.536 0.544 0.557 0.570 0.570
10.0 0.709 0.711 0.717 0.723 0.738 10.0 0.546 0.549 0.558 0.566 0.586
15.0 0.709 0.718 0.722 0.727 0.740 15.0 0.551 0.561 0.565 0.569 0.572
20.0 0.715 0.721 0.726 0.730 0.742 20.0 0.554 0.565 0.572 0.579 0.580
25.0 0.721 0.729 0.733 0.737 0.749 25.0 0.557 0.565 0.579 0.593 0.578
45◦ 60◦
Depth
Side of equivalent square (cm)
Depth
Side of equivalent square (cm)
(cm) 5 10 15 20 30 (cm) 5 10 15 20 30
1.5 0.479 0.480 0.486 0.495 1.5 0.392 0.396 0.402
5.0 0.483 0.485 0.489 0.497 5.0 0.397 0.400 0.404
10.0 0.491 0.492 0.494 0.500 10.0 0.405 0.406 0.412
15.0 0.500 0.500 0.500 0.505 15.0 0.411 0.414 0.417
20.0 0.505 0.505 0.506 0.511 20.0 0.416 0.421 0.425
25.0 0.512 0.514 0.515 0.519 25.0 0.424 0.429 0.431
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divergence with distance. For calculations at an off-axis point
within a physically wedged field, WF will change signifi-
cantly. For off-axis points along the principal axis in the gra-
dient direction of the wedge, Khan proposed that WF may be
approximated by the product of the central-axis WF and the
corresponding off-axis profile value measured for the largest
available wedged-field.84 This method agreed within 3% with
6-MV measurements for a calculation points positioned in
the geometric center of the asymmetric field for an exter-
nal wedge. A few years later, Georg85 proposed two alterna-
tive methods consistent with the ESTRO protocol. Each of
these methods employed a primary wedge factor measured
in a mini-phantom, as well as wedged-field output ratios and
TPRs. Although this approach compares well with the mea-
surement approach,86 it is not consistent within the formalism
presented in this report.
Both Smulders et al.86 and Mihailidis et al.87 have pro-
posed methods for off-axis wedged calculations which use
open field dosimetry parameters combined with wedged-field
off-axis ratios. The method of Smulders and co-workers used
a product of off-axis WFs for distances parallel to and per-
pendicular to the gradient direction of the wedge. Wedged
OARs were taken as the ratio of measured doses in phantom
for symmetric fields centered off and on the central axis. The
measured OARs for both 6- and 18-MV beams on an Elekta
internal wedge showed only a small field size dependence,
whereas the 18-MV results demonstrated a large depth depen-
dence. Mihailidis and co-workers equated wedged OARS to
primary OARs measured using techniques employed for open
fields.70 Their results also demonstrated good agreement (i.e.,
within 2%) with measured doses for 6- and 18-MV beams
with 15◦ and 45◦ external wedges.
For calculations at off-axis points along the principal
axis in the nongradient direction, additional corrections
may be necessary in addition to open field OARs. Chui
and LoSasso,88 first demonstrated differences between off-
axis wedged and open field profiles, measured for external
wedged-fields. Storchi and Woudstra89 proposed using open
field OARs in this direction, but at a depth increased by the
water equivalent thickness of the wedge at that point. Myler
and Szabo,90 obtained agreement within 1% by multiplying
central axis WFs with off-axis correction factors. These fac-
tors were determined by measuring the effective wedge atten-
uation coefficient as a function of off-axis position.
The use of wedged-field off-axis ratios is not consistent
with this protocol, as the WF is defined at the change in dose
rate at the calculation point. Nevertheless, the above tech-
niques may be used to determine WF at off-axis points. In
most of the above techniques, it may be necessary to remove
the open-field OAR values from these results to avoid double
counting the OAR in the final calculation.
To avoid complications associated with off-axis calcula-
tions; this task group recommends that every attempt be made
to keep this calculation on the central axis. If this cannot
be avoided, users are encouraged to verify the dose per MU
at the calculation point by measurement, particularly if the
field geometry is complex or outside the range of tabulated
data.
3.B.1.i.ii. Nonphysical wedges. The same concepts
that apply in calculating MUs with a physical wedge apply
in calculating MUs with a nonphysical or filterless wedge.
Wedge factors for both physical and nonphysical wedges de-
pend on the selection of wedge angle and energy. The main
difference is the dependence on field size and depth of calcu-
lation. The field-size dependence is highly dependent on the
software that drives the filterless wedge, whereas the depth
dependence is nearly eliminated due to the removal of the
physical filter beam hardening.
A number of researchers have derived methods to pre-
dict the WF for Varian’s EDW treatment fields. Liu et al.91
extended their method adopted for DW to EDW. In this ef-
fort, they remove the majority of the field-size dependence by
defining a normalization function determined from the STT
value for the final moving jaw position. They then calculate a
normalized WF according to the output for the EDW and the
Normalized Golden STT value for the final jaw position. It is
important to point out that the normalized WF defined in this
work may not be used within this protocol because it requires
both an additional normalization function, as well as an in-air
output ratio determined within the EDW field. In a follow-up
publication, however, Liu et al.92 used this approach to deter-
mined WF consistent with this report.
Additional methods have been proposed to determine the
WF from the MU fraction model for EDW. Papatheodorou
et al.93 determined the WF using an exponential model of the
GSTT for the 60◦ EDW. Klein et al.94 derived a more complex
method according to a technique that utilizes the manufac-
turer’s method of constructing a STT by a fitting polynomial.
The algorithm for the WF depends on the fixed-jaw position
and energy-dependent correction factors.
Although the MU fraction model accurately predicts WF
for most clinical cases, differences of ∼4% exist between
WF measured for larger field size and wedge angles.95 A
number of papers have been published to improve agreement
between calculated and measured data. Using an exponen-
tial model of dose outside the field, Gibbons95 formulated
an analytic algorithm for the WF that demonstrated agree-
ment within 2% to measured data in the center of symmet-
ric and asymmetric fields. Prado et al.96 used an empirical
formula to determine the dose to arbitrary points within the
field. Miften et al.97 determined a scatter dose correction de-
termined from the differences between measured and calcu-
lated WF for a 60◦ EDW. Finally, Yu98 and Kuperman99 mod-
ified the MU fraction model by shifting the calculation point
in the Y-direction (i.e., along the direction of jaw motion), al-
though the magnitude and field size dependence of this shift is
controversial.100
The methods above also apply for calculations to points
along the principal axis in the wedge-gradient direction. In
these cases, the MU fraction model equates the WF to the
fraction of MUs delivered, while the off-axis calculation point
is in the direct beam. These models therefore approximate the
fraction of dose delivered to the off-axis point of calculation,
consistent with the definition of WF within this protocol. Be-
cause the change in dose for nonphysical wedges in the non-
gradient direction is negligible,101 only the off-axis distance
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FIG. 6. Measured 6-MV EDW wedge factors for three different Varian ma-
chines represented by solid, dashed, and dotted lines. The close agreement
between multiple machines allows a common wedge factor table for use in
MU calculations (Ref. 94).
parallel to the wedge-gradient direction should be used as in-
put in determining WF. However, the radial off-axis distance
x (projected to 100 cm) should still be used in calculating the
OAR.
The method of choice for a clinic may be somewhat depen-
dent on the clinic’s resources and capabilities. A clinic may
calculate a subset of WF to be used in a look up table for
either manual or computer-based applications. The one com-
forting aspect of using either an algorithm or fixed tables is
that a WF for a given energy is independent of treatment ma-
chine. Therefore, one algorithm or one table can be used for a
single energy. Klein et al.,94 compared the measured WFs for
three accelerators and found differences of less than 0.5% on
average, with no difference more than 1.5% (see Fig. 6).
The Siemens VW implementation uses an analytic model
to determine the jaw position, rather than the tabular methods
employed by EDW. For a desired wedge angle θ , the moving
jaw position and dose rate are varied during treatment delivery
in order to deliver a pattern of energy fluence denoted by
(x) = ec(E)μx tan θ , (18)
where x is the distance from the central axis, μ is an effective
linear attenuation coefficient in water, and c(E) is a energy-
dependent calibration factor.
The Siemens VW also differs from the EDW in that the
programmed MU is the number of MU the central axis re-
mains within the direct beam. Thus, within the MU fraction
model, the WF for the virtual wedge is unity. As is the case
for the EDW wedge factors, investigators102–104 have found
that the WF is unity for most cases with the exception of the
60◦, large-field VW fields.
For points of interest away from the central axis, the MU
delivered across the beam can be described according to the
following formula:
MU(x) = MU(0)e−c(E)μx tan θ , (19)
FIG. 7. Example of a MU versus coordinate curve for the virtual wedge.
Displayed are MU(x), the number of monitor units given, while a point at
position x is irradiated, versus off-axis position x. The moving jaw is initially
at the position of the opposing jaw (xmin), with a minimum gap width, gap,
of 1 cm projected at SAD (Ref. 103).
where MU(x) = the MU required to deliver the desired dose
to position x (see Fig. 7).
For both EDW and VW, it is recommended that the con-
stancy of the WF be confirmed by measurement, especially
for large wedge angle and field size combinations.
3.B.1.j. SSD0. For calculations with photon beams
within this protocol, the nominal SSD or SPDs have been
used to compute the inverse-square correction. However, it
has been pointed out that extra-focal radiation will contribute
to small but detectable deviations from the inverse-square law
for photon beams.105 The effect of this on most clinical cal-
culations is typically negligible, but should be verified by the
physicist at the time of machine commissioning for the range
of SSDs expected to be used in the clinic. This is particularly
true for treatments at greatly extended SSDs, such as those
performed for total body irradiation. The reader is referred to
the AAPM Task Group 29 report for these situations.106
3.B.2. Measurements of dosimetric quantities:
Electron beams
3.B.2.a. Dose per MU under normalization conditions
(D′0). For electron beams within this protocol, the dose rate
or dose per MU, D′0, under normalization conditions is set to
be 1.0 cGy/MU.
3.B.2.b. Percent depth dose. The recommendations of
the AAPM Task Group 70 report38 should be followed for
the measurement of depth dose curves for electron beams. If
a cylindrical ionization chamber is used, the effective point of
measurement of the chamber must be taken into account. This
requires that the complete depth ionization curve be shifted to
shallower depths (i.e., upstream) by a distance proportional to
rcav, where rcav is the radius of the ionization chamber cavity.
For electron beams, the shift is taken as 0.5 rcav.7 If a well-
guarded plane-parallel ionization chamber is used, no shift in
depth-ionization curves is needed. Converting relative ioniza-
tion to relative dose for ionization chambers requires multi-
plying by a stopping power ratio and a replacement factor,
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TABLE VII. Electron output factors. Electron output factors versus field size
for various applicators for a 9 MeV beam on a Varian Clinac 2100C (SSD
= 100 cm).
Field size Applicator size (cm
2)
(cm2) 10 × 10 15 × 15 20 × 20 25 × 25
2 × 2 0.843 0.846 0.824 0.812
3 × 3 0.908 0.908 0.891 0.871
4 × 4 0.963 0.954 0.936 0.911
5 × 5 0.991 0.982 0.962 0.936
6 × 6 1.003 0.997 0.976 0.951
7 × 7 1.005 1.004 0.983 0.960
8 × 8 1.003 1.006 0.986 0.964
10 × 10 1.000 1.003 0.985 0.965
12 × 12 0.997 0.980 0.962
15 × 15 0.992 0.976 0.955
20 × 20 0.981 0.950
25 × 25 0.955
both as a function of depth. The expression given by Burns
et al.,107 which is also in the TG-70 Report, should be used
for the stopping power ratio, and the replacement correction
factor should be as described in the TG-25 report.7
3.B.2.c. Output factors. At the time of beam commis-
sioning, the field size dependence of the output is measured
as a function of field size for each energy and applicator com-
bination at the reference SSD and dm. If the applicator ac-
cepts inserts, then output is typically measured for a range of
square insert sizes from 2 × 2 cm2 to the size of the open
applicator. Each of these measurements is taken at the depth
of dm, which may shift toward the surface for small inserts.
Table VII illustrates these data for a 9-MeV beam for a Varian
Clinac 2100C.
3.B.2.d. Effective SSDs. SSDeff can be used to determine
MU for electron fields at distances other than the nominal
SSD. SSDeff is dependent on electron energy and field size.
The method described by Khan108 may be used to deter-
mine SSDeff. Beam output is measured over clinically rele-
vant ranges of SSDs (100–120 cm, for example), field sizes,
and beam energies. For each field size and energy combi-
nation, a fit is made of the square root of the output ratio√
D′(ra, SSD0)/D′(ra, SSD0 + g) versus the gap, g, where
D′(ra, SSD0 + g) is the output measurement and the gap is the
distance between the treatment and nominal SSDs. A least-
squares fit of the data on each plot gives a slope that relates to
the SSDeff as follows:
SSDeff = 1
slope
− dm (20)
where dm is the depth of maximum dose on central axis for the
field of interest. SSDeff for field sizes that have not been mea-
sured can be interpolated. In cases of extreme field irregularity
or large gaps from SSD0, special dosimetry is recommended.
For a given applicator, there is a strong dependence of
SSDeff on insert size.109 Investigators have shown that SSDeff
is only weakly dependent on the applicator40, 110 so tables
of SSDeff versus insert size are clinically adequate. In fact,
TABLE VIII. Electron SSDeff table. Table of SSDeff averaged over applica-
tor size for a Varian Clinac 2100C. For this table, SSDeff is a function of
insert size and energy only.
Energy (MeV)Insert size
(cm2) 6 9 12 16 20
4 46.2 61.1 72.5 76.4 76.6
6 62.2 74.7 80.2 81.8 80.6
8 77.6 83.8 83.2 83.6 82.7
10 82.9 85.9 86.8 85.5 83.8
15 90.7 90.9 90.1 90.0 89.7
20 90.0 91.8 91.4 90.9 92.0
25 90.7 91.9 91.0 92.5 93.3
Sharma and Johnson111 suggested that a single SSDeff for
each energy can be used for field sizes larger than 10
× 10 cm2. Table VIII displays SSDeff, categorized by in-
sert size and energy. SSDeff is smallest for small fields and
low electron energy. For rectangular field sizes, it is recom-
mended that the geometric mean of SSDeff for each side be
used as the SSDeff, as this can be shown to be equivalent to
the square root method of Mills et al.112 The field size de-
pendence is caused by a lack of lateral scatter equilibrium for
small apertures.40, 113 Potential dose-delivering electrons near
the central axis are scattered out of the field and not fully re-
placed by electrons originating peripheral to the central axis.
The net loss of scatter to the central axis causes the fluence to
decrease with SSD more rapidly than the inverse-square law
predicts. The energy dependence is caused by the increased
outward scattering of low energy electrons, which also de-
creases the fluence to the central axis.
3.B.2.e. Air-gap correction factors (fair). The air-gap
correction factor fair is defined as the ratio of the electron
dose rate at the normalization depth at extended SSD to that
predicted using only inverse square corrections. This quantity
represents the deviation from the inverse-square law due to the
loss of side scatter equilibrium114 and is assumed independent
of applicator size. For an electron beam, fair is dependent on
the insert size and the SSD.
fair is determined by evaluating the following equation us-
ing square field output data at the standard SSD (SSD0) and
extended SSDs,
fair(ra, SSD) = D
′(ra, SSD)
D′(ra, SSD0)
·
[
SSD + dm(ra)
SSD0 + dm(ra)
]2
,
(21)
where D′(ra, SSD) is the measured output for the given SSD.
For rectangular fields, fair may be estimated using the
square-root method:
fair(L × W ) = [fair(L × L) × fair(W × W )] 12 , (22)
where the same applicator is again implicit in the equation.
It should be noted that nominal rather than virtual SSDs are
used in Eq. (21). Although this method differs from the TG-25
implementation,7 the corresponding difference in the inverse
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TABLE IX. Electron air gap factor table. Air gap factor versus field size (de-
fined at SSD = 100 cm) and SSD for a 9 MeV electron beam on a Varian
Clinac 2100C. Values for fair < 0.95 are italicized to indicate conditions of
lateral electronic disequlibrium. Taken from Ref. 45.
Field size SSD (cm)
(cm2) 100 105 110 115 120
2 × 2 1.000 0.882 0.743 0.611 0.505
3 × 3 1.000 0.946 0.878 0.792 0.715
4 × 4 1.000 0.942 0.902 0.862 0.815
6 × 6 1.000 0.978 0.954 0.940 0.915
10 × 10 1.000 0.984 0.972 0.961 0.955
15 × 15 1.000 0.988 0.978 0.970 0.963
20 × 20 1.000 0.987 0.975 0.971 0.963
25 × 25 1.000 0.987 0.982 0.974 0.970
square term is small and this small difference is absorbed into
the air-gap factor.
Table IX displays sample air-gap factors for a 9-MeV elec-
tron beam.
4. INTERFACE WITH TREATMENT-PLANNING
SYSTEMS
Dose calculation algorithms in external beam treatment
planning are often classified as correction-based and model-
based. The correction-based algorithms calculate the dose in
a patient by correcting the measured dose distribution in a wa-
ter phantom to account for beam geometry, beam modifiers,
patient contours, beam aperture opening, and tissue hetero-
geneities. The model-based algorithms compute the dose in
a patient from “first principles” using a model of radiation
transport. Computations of dose using either correction-based
or model-based algorithms require measurement of beam data
in a water phantom. For correction-based algorithms, the mea-
sured data are first parameterized into functions that are sub-
sequently used to reconstitute each treatment beam used in a
patient treatment plan. For model-based algorithms, the mea-
sured data are used to define the description of the beam. The
fundamental difference between the two classes of algorithms
is that model-based calculations do not reconstitute measured
data before correcting it for the clinical situation.
Regardless of which type of algorithm is used, the
treatment-planning system should be able to report the dose
from each beam to any point in the dose matrix for which the
user will perform the manual calculation. Users can then ver-
ify the treatment-planning systems reported MUs using calcu-
lation points located in regions of less uncertainty (i.e., away
from block edges or heterogeneities). Additional information
detailed below should also be provided to the user to aid in the
MU calculation. Unfortunately, there are a number of differ-
ent terminologies used in different vendor implementations.
It is critical that treatment planning vendors specify quanti-
ties that are consistent with the nomenclature defined in this
and other task group reports.
MU calculations should always be performed in conjunc-
tion with computer treatment plans to serve as an independent
verification of the treatment plan determined MUs. Differ-
ences in results may be due to either deficiencies in the “man-
ual” calculation algorithm (i.e., due to the approximations in-
herent flat, water-phantom based calculation), to errors in the
treatment-planning systems MUs (i.e., due to errors in input
parameters, input beam data, modeling, etc.), or to both. As
discussed in the quality assurance (QA) section, differences
exceeding reasonable limits should be investigated, for exam-
ple, via direct measurement. A completely independent cal-
culation would require that all input data be obtained outside
the planning system. This is rarely practical or necessary, if it
has been determined that the planning system is accurate in
providing correct input data for the independent check. Fur-
thermore, vendor provision of appropriate calculation input
data (e.g., radiological depth, equivalent square) significantly
aids the user’s determination of the source of the discrepancy.
Quality assurance measures for treatment planning systems
have been addressed in the AAPM Task Group 53 report.115
For treatment plans performed on CT datasets, vendors
should provide both the physical and radiological depth of
each beam to the calculation point. These reported depths
should be those measured along the path from the source to
the point of calculation, for example, accounting for changes
in patient anatomy at off-axis positions. Verification of the
planning algorithm should be made before using depths re-
ported for noncoplanar beams. Further caution should be
taken for noncoplanar calculations, as the accuracy of depth
determination will be compromised by coarse slice spacing or
incomplete datasets.
Users performing manual calculations must rely on the
equivalent square of the collimating jaws to determine the
argument for Sc. Depending on the treatment-planning algo-
rithm employed, more complex calculations of head scatter
including primary and extra-focal components can be made,
even including the effects of additional apertures such as
MLCs. For each beam, planning vendors should provide the
user with the equivalent square field size of a field that pro-
duces the same collimator output. For additional details, see
the AAPM TG-74 report.10
For Sp and TPR (or PDDN), users must estimate the equiv-
alent square of each field incident onto the patient. Treatment-
planning systems should provide more accurate equivalent
squares, incorporating corrections for patient anatomy (ex-
ternal and internal) as well as more accurate corrections
for irregular fields. These data can aid users in determining
the cause of differences between manual and TPS-calculated
MUs.
Users should take great care to ensure that the point of cal-
culation matches that referenced in the treatment plan output.
5. MU CALCULATIONS FOR IMRT FIELDS
At the time the task group was formed, methodologies for
performing independent checks of MU calculations for IMRT
treatment fields were not prevalent in the clinical environ-
ment. Since that time, a number of papers have been writ-
ten to address these types of calculations.116–128 Additionally,
several vendors of MU-calculation software have expanded
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their products to include MU calculations for IMRT fields.
Given the widespread use of these products, a discussion of
IMRT MU calculation methodology is warranted. This task
group report will give no recommended formalism, but will
discuss some general considerations. AAPM Task Group 219
is charged with investigating this area in greater detail.
5.A. Calculation methodologies
The IMRT Collaborative Working Group129 defined a
number of classes of IMRT delivery methods. Gantry-static
techniques are divided into segmental-MLC (SMLC) and
dynamic-MLC (DMLC) depending on whether the collimator
shape varies during irradiation. Gantry-dynamic techniques
include serial and helical tomotherapy, as well as volumetric
modulated arc therapy (VMAT). Each of these delivery meth-
ods presents unique challenges to the determination of MU.
Several papers have been written discussing the calculation
of MU for SMLC-IMRT. One of the first papers dealing with
the subject of IMRT MU calculations was the work of Boyer
et al.116 who derived an algorithm for IMRT MU calculations
for the Corvus treatment-planning system. In this algorithm,
the intensity-modulated field was modeled by an ensemble
of beamlets whose calculated dose was scaled by an inverse
square and primary off-axis ratio correction factors depending
on their location within the field. The total MU was scaled by
a modulation scale factor, representing the maximum number
of steps (per number of levels) required to achieve the de-
signed modulation between any two pair of opposing leaves.
The algorithm was designed for a one-dimensional sliding
window-type leaf-sequencing algorithm. The results agreed
within 4% for the cylindrical phantom studied.
The concept of subdividing the intensity-modulated field
into a number of beamlets was extended by both Xing
et al.,119 and Kung et al.118 Xing et al. extended the work
of Boyer to create an algorithm that was independent of the
leaf-sequencing method employed by the treatment-planning
system. Consider a SMLC-IMRT field of K segments that
may be subdivided into M beamlets. Let fk represent the frac-
tional MU delivered during the kth segment (fk = MUk/MU).
In Xing’s approach, if d0m is defined as the dose contribution
from the mth beamlet (per MU) when it is open, the dose from
the intensity-modulated field is given by
D = MU
M∑
m
Cmd
0
m, (23)
where
Cm =
K∑
k
[δm,Ak + α(1 − δm,Ak )]fk. (24)
In Eq. (24), δm,Ak is defined as 1 if beamlet m is in the
open area of segment k, and 0 otherwise, and α is the trans-
mission through the MLC leaf. The increase in MU needed to
deliver an intensity modulated field is given by the Cm factor.
All that remains within this formalism is the determination of
the beamlet dose, d0m. Both Xing et al. and Kung et al. used
this approach to compute isocentric doses using a modified
Clarkson integration method to add doses from outside beam-
lets or sectors. Yang et al.120 extended this work to include
calculations to arbitrary points on or off the central axis. Yang
also used a three source model to calculate the head scatter
for the fields. The improved algorithm demonstrated agree-
ment to within 3% with both ion chamber measurements and
doses computed with the Corvus system. More complex ap-
proaches have also been published to calculate irregular field
outputs from first principles.130
DMLC-IMRT fields represent an increased level of com-
plexity, as the number of control points within an intensity
modulated field is typically much larger than that for SMLC-
IMRT. Linthout et al.121 described a technique for verifica-
tion of DMLC-IMRT treatment delivery on a BrainLab No-
valis system. In this work, calculations were made by sum-
ming field segments of uniform intensity, rather than individ-
ual beamlets. Calculations were made to the isocenter and
the dose algorithm used was limited to homogeneous me-
dia. Chen et al.122 developed an algorithm for use in verify-
ing DMLC-IMRT treatments planned using a sliding window
leaf sequencing algorithm. This method was not restricted to
the isocenter and included the effects of leaf-end leakage.
Comparisons with 25 patients and 169 intensity modulated
fields demonstrated good agreement between the proposed
technique and doses calculated with the Eclipse treatment-
planning system.
Less data are available for tomotherapy-type delivery tech-
niques. Ayyangar et al.123 proposed a method to verify dose
calculations for the serial tomotherapy Peacock system. In
their paper, calculations are made by summing the dose from
open beamlets. The beamlet dose was computed using a pen-
cil beam model that incorporated profiles from the planning
system and an exponential fit to the TMR. Although this
method was used to generate fully independent isodoses dis-
tributions, point dose calculations were possible as well. Tsai
et al.131 also developed what they called a “quasiindepen-
dent” MU calculation that is based on the vane patterns from
the MIMiC collimators. For helical tomotherapy, Gibbons
et al.124 described an approach in which the total dose was
calculated as a sum of doses from each projection. The mod-
ulated projection field was approximated by a sum of equal
intensity segments that were used to compute the total dose.
For point-dose calculations to the center of the PTV, good
agreement was found between the proposed method and the
treatment-planning system for a number of phantom and pa-
tient plan calculations.
5.B. Task group recommendations
Due to the increased complexity of IMRT plans, well-
designed QA tests are required to validate treatment plans
for individual patients. Verification of a patient-specific IMRT
treatment plan is typically accomplished through dose mea-
surements of the plan recomputed on a clinical measure-
ment phantom. However, as pointed out by the AAPM IMRT
subcommittee’s guidance document on implementation of
IMRT,132 although such a QA procedure is valuable for test-
ing the accuracy of the delivery system, some errors in dose
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calculations (e.g., failure to remove the planning CT couch, an
incorrect patient CT dataset, or an incorrect CT-density table)
will not be detected using a phantom plan evaluation. The in-
ability to detect all errors is supported by the data from the
Radiological Physics Center’s independent audit of IMRT
delivery using their anthropomorphic QA phantoms, which
nearly a third of all institutions fail on their first attempt.133
Hence, a comprehensive QA program should include verifi-
cation of both the dose calculation and dose delivery.
This task group report recommends that a second check
dose calculation be used to verify IMRT treatment deliveries.
The use of a second independent check of machine time set-
tings (minutes or MUs) for a patient treatment is standard of
care in radiation therapy. Historically in medical physics, new
technologies have been implemented with extreme care be-
cause failure modes are unknown. As experience grows, qual-
ity assurance methods become more focused and efficient.
Consequently, we do not perform individual QA measure-
ments for three-dimensional conformal radiation therapy or
most other external beam treatments. Individual patient QA
measurements are currently performed for IMRT treatments
because they are still relatively new. We foresee a time in the
future, when confidence in IMRT delivery and treatment plan-
ning will be high enough that clinics will desire to replace
them with an independent calculation. As noted by the AAPM
IMRT Subcommittee report: “This is the norm for conven-
tional treatments and may become so for IMRT as the field
evolves.”132
6. QUALITY ASSURANCE
The treatment time set to deliver the prescribed dose to a
patient involves numerous steps from beam commissioning
to daily QA checks. Table VII in the Task Group 40 (TG-40)
report on “Comprehensive QA for Radiation Oncology” lists
the factors that affect the accuracy of the MU calculation.4
Each one of these steps, to some degree, should be considered
as part of a clinic’s QA program. The MU set calculated for a
patient’s treatment, whether by using the treatment-planning
system, inhouse developed calculation software, or manually
by looking up factors in tables, should always be verified by
another individual in an independent manner from the initial
calculation as recommended by TG-40. It is preferred that a
radiation oncology physicist be the reviewer; however when
there is only one physicist available, a dosimetrist or other
individual, authorized by the physicist, can be designated as
the reviewer. The goal of this MU verification is to minimize
the number of errors that may result in the dose delivery to
a patient early in the patient’s treatment. The MU verifica-
tion should occur prior to the patient’s first treatment; when
this is not possible, then it should be performed before the
third fraction is delivered or before 10% of the dose has been
delivered, whichever occurs first.4 More details regarding the
clinical application of this formalism described in this report,
as well appropriate action levels are contained in a separate
AAPM report.5
Verification of the MU calculation should include checking
all of the dosimetry factors used in the calculation of the treat-
ment time. These factors include the machine, modality, en-
ergy, SSD, or SAD, collimator setting, treatment depth, depth
dose data, TFs, WFs, OARs and any other parameter neces-
sary to calculate the monitor unit set. We recommend that the
individuals who performed the initial MU calculations and the
MU verification sign and date the calculations.
Prior to clinical use, the treatment-planning system from
which the patient monitor unit set is calculated should
undergo rigorous QA testing as outlined by the TG-53 report
on “Quality Assurance for Clinical Radiotherapy Treatment
Planning.”115 These tests include QA of the input data
(i.e., Can the system reproduce the input data correctly?),
algorithm verification to determine the accuracy of the dose
calculation algorithm itself, and calculation verification to
determine whether the results from the planning system agree
with experimentally measured dose values. Verification of
current beam modeling planning systems’ ability to calculate
dose correctly for many complex clinical situations is best
accomplished by ion chamber measurements in a water
phantom. Verification of heterogeneity calculations requires
special phantoms, both slab and anthropomorphic.34 The
planning systems’ dose calculation algorithm applicability
and limitations should be determined and then the dose cal-
culations for the complete range of clinical situations need to
be assessed. Once the user has confidence that their planning
system can calculate accurate MU sets for patients, then
attention to developing an independent means of verifying
the planning system’s calculation of MU is needed.
The best check is one that uses a different method of
calculation other than that used in the initial calculation. A
different computer calculation (inhouse or commercial MU-
calculation software, or other treatment-planning system) or
manual calculation technique is recommended. Many of the
newer treatment-planning systems calculate MU settings in
a manner that is not consistent with the formalism specified
in this report. It is the responsibility of the planning system
manufacturer to provide the system’s formalism for calculat-
ing monitor units to the physicist. The physicist should under-
stand how the planning system calculates dose and MUs in or-
der to be able to compare the initial MU calculation with the
independent calculation. For the model-based planning sys-
tems, we recommend the physicist use the formalism outlined
in this report to verify the MU set calculations. The physicist,
based on the accuracy and precision of the dosimetry data
used for the check, must also develop action criteria for the
agreement between the initial MU calculation and redundant
check. The criterion most often used in the radiation oncology
community is 2%–3% agreement between the initial calcula-
tion and the redundant check. There can be exceptions to the
action criteria, when the physicist understands the reason for
the differences or the limitations of the algorithms used
for the initial and redundant check calculations. An example
of the two calculations disagreeing is the failure of the initial
MU calculation or redundant check to incorporate the appro-
priate changes in depth dose as the beam is hardened by a
large angle wedge, which may or may not be accounted for
in the treatment-planning system and/or manual method. An-
other possible difference between the initial MU calculation
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and the independent check might result from not accounting
for missing tissue or curvature as normally observed with tan-
gential breast treatments.
There are two primary sources of dosimetry data that can
be used with the MU calculation formalism presented in this
report to perform a redundant MU check. The first and rec-
ommended source is to use your own measured data for each
therapy beam. Because the newer model-based treatment-
planning systems rely on less measured data, the physicist
may be required to perform additional dosimetry measure-
ments to develop a comprehensive set of dosimetry data for
each beam to be used in the redundant check. The physicist
should develop tables of dosimetry data ensuring the accuracy
of the data within each table and that any error introduced
by interpolation between two tabular points is minimized to
achieve an overall 2% accuracy for each MU calculation. As
a minimum, the physicist should have a full set of fixed SSD
depth-dose data and/or tissue-phantom ratio data, collimator
and phantom scatter factors, WFs (both field size and depth
dependent), tray factors and off-center ratios for the redun-
dant checks. The model based planning systems’ ability to
calculate accurately the dose to a point in phantom, which is
directly related to its ability to calculate accurately MU times,
should also be verified for several different clinically relevant
setups using ion chamber measurements. Examples of some
clinical situations that may require measurement verification
include calculations off axis using asymmetric fields both un-
der a large wedge and open field, calculations at depth for
highly irregular MLC field-size settings, calculations of out-
puts for small field sizes (<4 × 4 cm2) and calculations of
doses at depths less than dm.
A second and less rigorous source of dosimetry data for
the redundant checks can be the “standard data” for the par-
ticular make, model, modality, and energy of interest. Most
of the newer linear accelerators models are similar in de-
sign and are tuned to have the same basic dosimetry parame-
ters. However, occasionally a linear accelerator does not have
the same basic dosimetry parameters as the other accelera-
tors of the same make, model, and energy. For this reason
prior to any “standard data” use in a clinic, a set of mea-
surements must be made to ascertain whether these data in
fact matches the dosimetry parameters for the specific lin-
ear accelerator. Several publications,66 including the TG-46
report134 have provided the basic dosimetry data needed for
MU calculations. One has to realize that these standard data
are typically averages of measured data and therefore have
a slightly higher uncertainty (∼1%) compared to the actual
measured values for a specific accelerator. The Radiological
Physics Center (RPC) maintains a set of standard data for 129
different make/model/photon energy combinations. The RPC
data consist of output factors, depth dose data, in-air off-axis
factors, WFs and TFs, which are available to the radiation on-
cology community upon request. These standard data sets can
provide a unique independent redundant check mechanism for
most clinics.
Verification of the MU calculation technique used by a
clinic can also be performed by an independent quality au-
dit. The audit by an individual from outside of the clinic will
typically use an independent method for checking the MU set
calculations. Physicists from nearby clinics, consultant physi-
cists, local AAPM chapter physicists, and the RPC physicists
can provide this type of quality audit. The RPC conducts au-
dits of clinics participating in clinical trials in two ways. First,
by providing the clinic with several hypothetical patients for
specific treatments (reference or benchmark cases) and recal-
culating the dose delivered from the clinic’s MU set, although
using their calculation technique. This method allows the au-
ditor to isolate the individual parameters to discern any differ-
ences noted. Second, during on-site dosimetry-review visits
by the RPC, several treatment records for different treatment
sites are checked for accuracy, inclusion of all necessary in-
formation, and consistency of the dosimetry data used to cal-
culate the MU set. The independent audit is the most costly;
however, it provides the best redundant check of a clinic’s
MU set calculations to discover potential systematic errors
that might otherwise be missed if the clinic’s physicist per-
forms the redundant check.
Finally, we note that additional quality assurance measures
may be warranted for complex field shapes and/or patient ge-
ometries, where the accuracy of the MU algorithm is limited.
AAPM Task Group Report 114 has established agreement cri-
teria and presents specific action level guidelines for disagree-
ment between independent MU calculation methods.5 Patient
in vivo dosimetry may also be useful in verifying the results
of a computer treatment plan. The reader is referred to AAPM
Task Group 62 Report on diode in vivo dosimetry for more
information.135
7. SUMMARY OF RECOMMENDATIONS
We recommend that
1. The formalism embodied in Eqs. (1) and (3) for photon
beams, and Eq. (10) for electron beams should be used
for the calculation of monitor units.
2. For photon beams, the task group recommends that a
normalization depth of 10 cm be chosen for MU cal-
culations. If another depth is chosen, this depth shall
be greater than or equal to the maximum depth of dm,
determined from percentage depth dose measurements
for the smallest field size and greatest SSD.
3. For electron beams, the normalization depth for a
given field is taken to be the depth of maximum dose
along the central axis for the same field incident on a
water phantom at the same SSD.
4. Treatment planning software vendors should provide
data necessary to verify their calculation of MU
through this protocol. Vendors should specify quan-
tities that are consistent with the nomenclature and
definitions found in this and other AAPM task group
reports.
5. MU verification of patient plans should occur prior to
the patient’s first treatment; when this is not possible,
then it should be performed before the third fraction
is delivered or before 10% of the dose has been deliv-
ered, whichever occurs first.
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8. EXAMPLES
The following examples have been included to aid the user
in the application of the protocol to clinical problems. In all
cases, the tables included in the Appendix have been used to
perform the calculations.
8.A. Photon calculations
These example calculations use a 6-MV beam (Varian
Clinac 21EX), 100-cm SAD, with a 0.8 cGy/MU dose rate
at the normalization point (SSD0 = 90 cm, rc = 10 × 10 cm2,
d0 = 10 cm). The equivalent square of the collimator and ef-
fective field sizes has been determined using the A/P approx-
imation.
1. Calculate the MUs required to deliver 250 cGy to the
isocenter. Collimator field size of 10.0 × 15.0 cm2,
depth = 6 cm and no blocking.
Answer: This example is easiest to solve using
an isocentric technique. Using 4A/P, the equivalent
square field size for 10 × 15 cm2 is 12 × 12 cm2 and is
the appropriate field size for use with Sc, Sp, and TPR.
From Eq. (1), the MUs are
MU = D
D′0 · Sc(12) · Sp(12) · TPR(6, 12)
= 250 cGy(0.8 cGy/MU) · (1.008) · (1.020) · (1.143)
= 266 MU. (25)
The calculation may also be performed nonisocentri-
cally. Note that three different field sizes must be used:
the field size at the isocenter for Sc, the field size at
the surface for PDDN and the field size at the nor-
malization depth (i.e., surface + 10 cm) for Sp. An
inverse-square correction is also required. The equiv-
alent square of (12 cm)2 projects to (11.3 cm)2 and
(12.5 cm)2 at the surface and depth of 10 cm, respec-
tively. Using Eq. (3), the MUs are
MU = 250 cGy
(0.8 cGy/MU) · Sc(12) · Sp(12.5) · PDDN(6, 11.3, 94)100% ·
(
100
94 + 10
)2
= 250(0.8) · (1.008) · (1.024) · (1.231) · (0.925)
= 266 MU, (26)
where the PDDN has been taken from Table II
and corrected for the change in SSD using
Eq. (14).
2. Calculate the MUs required to deliver 90 cGy to the
isocenter of an AP lung field displayed in Fig. 8. The
collimator field size is 18.0 × 12.0 cm2, and the phys-
ical depth = 10.0 cm. The field is blocked using a
tertiary MLC and a 15◦ physical wedge is added to
the field. Repeat the calculation using a tissue hetero-
geneity correction using a radiological depth of 6 cm.
Answer: In this example, the effective field size is es-
timated to be 14 × 8 cm2 (equivalent square = 10.2
cm), which is used to determine Sp and TPR. Note that
some flexibility is allowed in this estimate: identical
results are obtained with an equivalent square range
of 9–13 cm. Since the MLC is tertiary, the collima-
tor field size is used for the argument Sc. The effec-
tive field size is used to determine the physical WF, al-
though little difference is found using either field size.
The calculated MUs are
MU = 90 cGy(0.8 cGy/MU) · Sc(14.4) · Sp(10.2) · TPR(10.2, 10) · WF(10.2, 10)
= 90 cGy(0.8 cGy/MU) · (1.015) · (1.002) · (1) · (0.711)
= 156 MU. (27)
The correction factor for the RTAR method [see
Eq. (7)] is equal to TPR(10.2,6) = 1.152, giving MU
= 135 for the heterogeneous calculation. Because the
WF for this wedge depends only slightly with depth,
the same answer is obtained using the radiological
depth in Eq. (27).
3. Calculate the MUs to deliver 45 cGy to the isocen-
ter (depth = 9.5 cm) of a superior–anterior oblique
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pituitary field. The collimator field size is asymmetric
(X1 = 2.0, X2 = 3.5, Y1 = Y2 = 3.5), with block-
ing (see Fig. 9) using a tertiary MLC. A 45◦ EDW is
added, in the Y1 orientation (Y2 jaw fixed). Repeat
the calculation to an off-axis point at the same depth,
located at (1,1) cm in the (X2,Y2) direction.
Answer: In this example, the equivalent square of the colli-
mator field size (5.5 × 7 cm2) is 6.2 cm2. The effective field
size at the isocenter is estimated to be 4 × 5 cm2. The EDW
factor is determined predominately by the fixed jaw position
(Y2 = 3.5 cm) and has been calculated to be 0.845 using an
analytic equation.95 The total MUs are given by
MU = 45 cGy
D′0 · Sc(6.2) · Sp(4.4) · TPR(4.4, 9.5) · WF(Y2 = 3.5)
= 45 cGy(0.8 cGy/MU) · (0.978) · (0.914) · (1.023) · (0.845)
= 73 MU. (28)
For the off-axis calculation, because the calculation point is closer to the fixed jaw, it remains in the open field longer and the
WF is increased. The off-axis distance used for this calculation is the distance along the gradient (or Y) direction of the wedge,
which is 1 cm in this case. Again, using the same analytic formula, the WF is found to be 0.892. An open-field OAR is also
required, but the radial off-axis distance of 1.4 cm is used in this function. The total MUs in this case is given by
MU = 45 cGy
D′0 · Sc(6.2) · Sp(4.4) · TPR(4.4, 9.5) · WF(1, Y2 = 3.5) · OAR(1.4, 9.5)
= 45 cGy(0.8 cGy/MU) · (0.978) · (0.914) · (1.023) · (0.892) · (1.005)
= 69 MU. (29)
8.B. Electron calculations
These example calculations use a 9-MeV beam (Varian
Clinac 21EX), with a 1.0-cGy/MU dose rate at the nor-
malization point (SSD0 = 100 cm, rc = 10 × 10 cm2,
dm = 2.1 cm).
1. Calculate the MUs required to deliver 200 cGy to a
depth of dm at 100-cm SSD for a 6 × 10-cm2 insert
in a 15 × 15-cm2 applicator.Answer: For the stan-
dard 100-cm SSD, the MU can be obtained using
Eq. (10). Using data from Table VII and the square-
root rule for the output factor, the total MUs are
given by
MU = 200 cGy(1.0 cGy/MU) · √0.997 · 1.003
= 200 MU. (30)
2. Repeat the calculation for a treatment at 110 SSD.
Answer: The problem may be solved using either the effec-
tive SSD technique or the air-gap technique. For the effective
SSD technique, SSDeff is found in Table VIII using the field
size of the insert (6 × 10-cm2). For the rectangular field, the
geometric mean of the corrections for each of the dimensions
of the insert size is used. The MUs are found using Eq. (11),
MU = 200 cGy
(1.0 cGy/MU) · √0.997 · 1.003 ·
(
74.7 + 2.1
74.7 + 2.1 + 10
)
·
(
85.9 + 2.1
85.9 + 2.1 + 10
)
= 252 MU. (31)
The air-gap factor data required for this problem are found in Table IX. The square-root rule is used for both the output factor
and the air-gap factor. The MUs using the air-gap technique are found using Eq. (12),
MU = 200 cGy
(1.0 cGy/MU) · √0.997 · 1.003 ·
(
100 + 2.1
100 + 2.1 + 10
)2
· √0.954 · 0.972
= 250 MU. (32)
Note that these two techniques may not give the exact same answer.
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FIG. 8. Beam’s eye view DRR for photon problem #2.
APPENDIX A: DERIVATION OF MONITOR UNIT
EQUATIONS
Appendix A outlines the derivation of Eqs. (1) and (3) for
photon beam calculations on the central axis. For off-axis cal-
culations, the reader is encouraged to refer to derivation con-
tained within the AAPM Task Group 74 report.10
FIG. 9. Beam’s eye view DRR for photon problem #3.
The generic equation to determine MUs may be written
MU = D
D′
, (A1)
where D is the prescribed dose, and D′ is the dose rate at
the point of calculation. The dose rate, i.e., dose per mon-
itor unit (Linac) or dose per unit time (Co-60), at an arbi-
trary point may be calculated in terms of the dose rate to
the point of normalization, D′0. D′0 is determined under nor-
malization conditions of depth, d0, field size, r0, and source-
surface distance, SSD0, or source-normalization point dis-
tance, SPD0 (i.e., SPD0 = SSD0 + d0). This calculation may
be done either using isocentric or nonisocentric dosimetry
functions.
1. TPR (“isocentric”) method
Consider point 1 in Fig. 10, located at depth d, source-
point distance SPD, collimator field setting rc, and effective
field size at depth, rd. Let D′1 be the dose rate at 1, D′2 be
the dose rate at 2, etc. Referring to Fig. 10, the dose rate at 1
may be written in terms of the normalization dose rate, D′0, at
point 8,
D′1
(
D′1
D′2
)
×
(
D′2
D′3
)
×
(
D′3
D′4
)
×
(
D′4
D′5
)
×
(
D′5
D′6
)
×
(
D′6
D′7
)
×
(
D′7
D′8
)
× D′8
= WF(d, rd )×TPR(d, rd ) × TAR(do, rd )×
(
SPD0
SPD
)2
×
⎛
⎜⎜⎝ 1
TAR
(
do, rd
(
SPD0
SPD
))
⎞
⎟⎟⎠×
⎛
⎜⎜⎝
TF × Sp
(
rd
(
SPD0
SPD
))
Sp(rc)
⎞
⎟⎟⎠
×
(
Sc,p(rc)
1
)
× D′0.
At the reference depth do, the ratio of TARs may be written in
terms of Sp,
TAR(do, rd )
TAR
(
do, rd
(
SPD0
SPD
)) = Sp(rd )
Sp
(
rd
(
SPD0
SPD
)) .
So that the equation becomes
D′1 = WF(d, rd ) × TPR(d, rd ) ×
(
SPD0
SPD
)2
× TF × Sp(rd ) × Sc(rc) × D′0. (A2)
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FIG. 10. Diagram illustrating derivation of isocentric MU equation.
2. PDD (“nonisocentric”) method
Consider point 1 in Fig. 11, located at depth d, off-axis
distance x (projected to the isocenter), source-surface distance
SSD, collimator field size rc, and effective field size on the
surface, r. Let D1 be the dose rate at 1, D2 be the dose rate at
2, etc. Referring to Fig. 11, the dose rate at 1 may be written
in terms of the normalization dose rate, D′0, at point 8,
D′1 =
(
D′1
D′2
)
×
(
D′2
D′3
)
×
(
D′3
D′4
)
×
(
D′4
D′5
)
×
(
D′5
D′6
)
×
(
D′6
D′7
)
×
(
D′7
D′8
)
× D′8
= WF(d, rd ) × PDDN (d, r, SSD)100%
× TAR
(
d0, r
(
SSD + d0
SSD
))
×
(
SSD0 + d0
SSD + d0
)2
×
⎛
⎜⎜⎝ 1
TAR
(
do, r
(
SSD0 + d0
SSD
))
⎞
⎟⎟⎠
×
⎛
⎜⎜⎝
TF × Sp
(
r
(
SSD0 + d0
SSD
))
Sp(rc)
⎞
⎟⎟⎠×
(
Sc,p(rc)
1
)
× D′0.
Substituting for the TARs as above, the equation becomes:
D′1 = WF(d, rd ) ×
PDDN (d, r, SSD)
100%
×
(
SSD0 + d0
SSD + d0
)2
× TF × Sp
(
r
(
SSD + d0
SSD
))
× Sc(rc) × D′0 (A3)
Medical Physics, Vol. 41, No. 3, March 2014
031501-30 Gibbons et al.: Monitor unit calculations for photon and electron beams 031501-30
FIG. 11. Diagram illustrating derivation of nonisocentric MU equation.
APPENDIX B: CALCULATION OF Sc
USING A PEV MODEL
1. PEV of jaws
In order to take into account the difference in distance of
the upper and lower jaws from the sources, the exposed re-
gion of the sources from PEV needs to be included in the
model. Figure 12 is a schematic diagram of the cross-section
of the treatment head, showing the relative positions of the
flattening filter, monitor chamber, and upper and lower jaws.
The area of the flattening filter which is “visible” from the
point of calculation is displayed in the figure. It is clear from
the figure that for the same setting at isocenter, the collima-
tor closer to the source projects to a smaller opening in PEV.
The upper jaw setting (rjU) is scaled by a reduction factor F
to produce the equivalent setting of the lower jaw that pro-
vides the same opening in PEV. From the PEV projection
geometry,
F = c(a − b)
b(a − c) , (B1)
where c is the source to upper jaw distance, a is the source to
calculation point distance, and b is the source to lower jaw dis-
tance. Since most calculation points are close to the isocenter
except for extended SSD treatments, a can be approximated
by the SAD. For treatment at extended distances, this will in-
troduce an error typically less than 1%. The side of the equiv-
alent square will then be136
rc = (F + 1) · rjU · rjL
F · rjU + rjL . (B2)
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FIG. 12. Points eye view of upper and lower jaws. Schematic diagram of
the treatment head showing flattening filter, monitor chamber, and upper and
lower jaws. The lower jaws have been rotated by 90◦ for clarity.
The factor (F + 1) in Eq. (B2) ensures that square jaw settings
at isocenter will produce equivalent squares of the same size.
2. PEV of all collimators
For fields that have field shaping collimator (blocks or
MLC) much closer to the point of calculation than the jaws,
the area of the sources that is visible from the PEV may be
partly determined by the field shaping collimator (Fig. 12).
In order to estimate the area in the PEV, some scaling of the
jaw setting is necessary. The scale factor formula of Eq. (B1)
can also be used. Since it is easier to scale the straight jaw
edges than the shaped field edges, the upper jaw and lower
jaw settings are reduced by their corresponding scale factors
to equivalent sizes of the field shaping collimator
FU = U (A − M)
M(A − U )
FL = L(A − M)
M(A − L) , (B3)
where FU is the reduction factor for the upper jaws and FL is
the reduction factor for the lower jaws, U is the source to up-
per jaw distance, L is the source to lower jaw distance, M is the
source to field shaping collimator distance, and A is the SAD.
The scaled jaw edges are drawn on the beam’s eye view plot
(BEV) or simulation film with the reduced settings to generate
the PEV. The side of the equivalent square sM of the irregu-
lar area of the source that is visible in the PEV is estimated
with the same method described above for the treatment
field. The equivalent square sM is then scaled by a factor f
to give
rc = f · sM, where
f = (0.5)FU + FL
FUFL
. (B4)
The factors FU, FL, and f are constants for a given treatment
machine and can be tabulated. Except for the scaling of the
field sizes, the above procedure is very similar to the esti-
mation of the equivalent square in the BEV. For most clin-
ical cases, the jaw settings reduced by FU and FL define a
rectangle totally inside the shaped field in PEV, the equiva-
lent square is determined only by the jaws and the method in
Appendix B above gives identical result.
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